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Lipids serve as structural components of biological membranes. Additionally, a small 
subset of lipids serve as signaling molecules. Phosphoinositide (PPI) lipids are a class 
of lipids that are low in abundance, but nonetheless control a variety of signal 
transduction pathways and play crucial roles in cellular homeostasis. PPI species are 
generated by phosphorylation of phosphatidylinositol (PI) on the 3, 4, or 5 position of its 
inositol ring head group in every combination to yield a total of seven PPI species. The 
levels of these lipids are dynamically regulated by PPI lipid kinases and phosphatases 
that interconvert PPI lipids in response to stimuli. The generation of a specific PPI 
species on a membrane leads to the recruitment of distinct effector proteins that can 
then perform downstream functions. 
 
The dynamic regulation of PPI lipids suggests that in addition to being required for 
specific pathways, changes in PPI lipids may drive downstream processes. Most of the 
downstream functions of PPI lipids have been identified in studies that use knockout or 
knockdown of PPI kinases to deplete a specific PPI lipid and thereby test the necessity 
for that PPI species in a process. However, little is known about the impact of elevating 
phosphoinositides. Understanding the impact of elevating phosphoinositides is critical 
as the levels of PPI lipids can be dynamically elevated in response to stimuli. 
 xii 
To test this hypothesis, we elevated phosphatidylinositol-3-phosphate (PI3P) levels by 
generating hyperactive alleles of the yeast phosphatidylinositol 3-kinase, Vps34. We 
find that hyperactive Vps34 has complex effects on cellular function. Hyperactive Vps34 
drives phosphatidylinositol 3,5 bisphosphate (PI(3,5)P2) synthesis during hyperosmotic 
shock and retrograde transport from the vacuole. This demonstrates that elevating PI3P 
can accelerate some pathways and is rate limiting in those pathways. We also show 
that hyperactive Vps34 does not affect ESCRT (endosomal sorting complexes required 
for transport) function at endosomes or on the vacuole. Thus, elevating PI3P does not 
always increase the overall rate of a complex pathway. We also show that elevating 
PI3P can delay a pathway. Hyperactive Vps34 does not affect the induction of 
autophagy, but inhibits late steps in autophagy, in part via a delay in disassembly of the 
autophagy machinery from the surface of mature autophagosomes and also a delay in 
fusion of autophagosomes with the vacuole. This latter defect is likely due to a more 
general defect in vacuole fusion, as evidenced by an increase in the number of vacuole 
lobes per cell, which is consistent with a defect in homotypic vacuole fusion. 
 
Overall, these studies suggest that stimulus-induced elevation of PI3P levels regulates 
some, but not all, PI3P-dependent membrane trafficking pathways and that 
phosphoinositide lipids are commonly rate-limiting in pathways where they are required. 
Because the hyperactive Vps34 mutations we have identified are conserved in the 
mammalian Vps34 homolog PIK3C3, we think it is likely that these mutations in PIK3C3 
will elevate PI3P. Thus, in the future, this work provides a roadmap to test the 







Lipids are generally structural components of a biological membrane. In addition, a 
small subset of lipids can also act as signaling molecules. Phosphoinositide (PPI) 
signaling lipids are a low abundance class of molecules that control a variety of signal 
transduction pathways and play crucial roles in cellular homeostasis. PPI species are 
generated by phosphorylation of phosphatidylinositol (PI) on the 3, 4, or 5 position of its 
inositol ring head group in every combination to yield a total of seven PPI species. All 
seven species can be detected in mammalian cell types, whereas only four are readily 
detectable in Saccharomyces cerevisiae. In cells, the levels of these lipids are 
dynamically regulated by PPI lipid kinases and phosphatases that interconvert PPI lipids 
in response to stimuli (Strahl and Thorner, 2007; Sasaki et al., 2009; Balla, 2013; 
Shisheva et al., 2015; Wallroth and Haucke, 2018; Dickson and Hille, 2019) (Figure 
1.1). The dynamic regulation of PPI lipids is best demonstrated during hyperosmotic 
shock in S. cerevisiae, which leads to a transient 15 to 20-fold elevation in
 
1 Sections of this chapter are adapted from a published paper: Steinfeld, N., Lahiri, V., Morrison, A., 
Metur, S.P., Klionsky, D.J., and Weisman, L.S. (2021). Elevating PI3P drives select downstream 
membrane trafficking pathways. Mol Biol Cell 32, 143-156. 
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phosphatidylinositol 3,5 bisphosphate (PI(3,5)P2) via activation of the PI3P 5-kinase, 
Fab1 (Duex et al., 2006). The changes in PPIs are controlled spatially by the specific 
localization of lipid kinases and phosphatases, and temporally via specific activation of 
these enzymes. 
 
The generation of specific PPI species on membranes recruits distinct effector proteins 
that regulate downstream pathways (reviewed in (Schink et al., 2016)). An assumption 
in the field is that these PPI lipids are coordinated to control complicated multi-step 
pathways. However, this is generally difficult to document. One pathway where 
coordination occurs is in the interconversion of PPI lipids regulating clathrin-mediated 
endocytosis (CME) in mammals (reviewed in (Kaksonen and Roux, 2018)). CME begins 
with the generation of PI(4,5)P2 from PI4P by PIPK1 on the plasma membrane (Barbieri 
et al., 2001; Di Paolo et al., 2004), leading to the recruitment of a number of critical 
clathrin adaptors, including AP-2 (Rohde et al., 2002; Padron et al., 2003), CALM (Ford 
et al., 2001; Itoh et al., 2001), and other clathrin adaptors and proteins that induce 
membrane curvature (reviewed in (Posor et al., 2015)). The recruitment of synaptojanin 
isoform p170 is then thought to turnover PI(4,5)P2 to PI4P (Perera et al., 2006), 
enabling the phosphorylation of PI4P to PI(3,4)P2 by PI3KC2A (Posor et al., 2013). 
PI(3,4)P2 is believed to then further recruit SNX9, leading to increased membrane 
curvature and dynamin recruitment (Schoneberg et al., 2017). Following vesicle fission, 
another synaptojanin isoform, p145, is recruited, dephosphorylating the remaining 
PI(4,5)P2 to PI (Perera et al., 2006), while at the same time, PI(3,4)P2 recruits auxilin-
HSC70 machinery to disassemble clathrin from the surface of vesicles (Lemmon, 2001; 
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Massol et al., 2006). Finally, OCRL1 turns over the remaining PI(4,5)P2 to PI (Cauvin et 
al., 2016) and phosphoinositol 4-phosphatase converts PI(3,4)P2 to PI3P, completing 
CME and giving the newly formed vesicle an endosomal identity (Zoncu et al., 2009). 
These intricately regulated pathways in mammalian systems are simplified in yeast, as 
yeast contain only 4 PPI lipids: PI3P, which can be converted into PI(3,5)P2, and PI4P, 
which can be converted into PI(4,5)P2. This simplified yeast system provides some 
advantages over mammalian systems, most importantly that it is easier to manipulate 
the levels of a single PPI lipid without affecting the levels of other PPI lipids. 
 
Identifying the yeast PI 3-kinase, Vps34, in S. cerevisiae 
PI3P was first identified as biochemically distinct from PI4P in fibroblasts using anion 
exchange on an HPLC (Whitman et al., 1988) and soon after was found to be present in 
yeast as well (Auger et al., 1989). PI 3-kinase activity was then rapidly purified from rat 
liver (Carpenter et al., 1990), bovine brain (Otsu et al., 1991), and fibroblasts (Escobedo 
et al., 1991) and attributed to a 110 kDa protein. The sequence of this 100 kDa protein 
was determined and found to have significant homology to the S. cerevisiae Vps34 
protein (Hiles et al., 1992). In vps34D cells, no PI3P could be detected, suggesting that 
Vps34, is the sole enzyme responsible for generating PI3P from PI in yeast (Schu et al., 
1993). In vitro, Vps34 is unable to use PI4P or PI4,5P2 as a substrate, suggesting that 





The pseudokinase, Vps15, is required for PI3P synthesis 
Before it was characterized as a PI 3-kinase, Vps34 was first isolated from a screen 
selecting for mutants that mislocalize a vacuolar carboxypeptidase Y (CPY)-invertase 
fusion protein from the vacuole to the cell surface and were additionally found to exhibit 
severe defects in delivery of Proteinase A (PrA) and Proteinase B (PrB) to the vacuole 
(Robinson et al., 1988). Additionally, vps34D cells exhibited temperature sensitive 
growth, sensitivity to osmotic stress, and defective vacuole inheritance, while 
maintaining relatively normal vacuole morphology (Herman and Emr, 1990). Of the 
other identified Vps mutants, only Vps15 exhibited the same phenotypes as Vps34, 
suggesting that Vps34 and Vps15 could act in the same step of the vacuole protein 
sorting pathway (Banta et al., 1988; Herman et al., 1991a; Herman et al., 1991b). Soon 
after, Vps15 and Vps34 were found to interact by immunoprecipitation and chemical 
crosslinking (Stack et al., 1993). Moreover, similar to vps34D cells, vps15D cells do not 
produce detectable levels of PI3P (Stack et al., 1993). 
 
The precise mechanism by which Vps15 regulates Vps34 kinase activity is not agreed 
upon. Vps15 is myristoylated at its N-terminus, though mutating the Vps15 
myristoylation site does not lead to a defect in CPY maturation unless combined with 
other mutations (Herman et al., 1991b). Due to its sequence conservation, Vps15 was 
first proposed to be a protein kinase (Herman et al., 1991a). Point mutations in 
conserved amino acids in the Vps15 kinase domain led to defects in sorting of CPY 
similar to those observed in vps15D cells (Herman et al., 1991a). Additionally, these 
point mutants abolished phosphorylation of Vps15 in cells, raising the possibility that 
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Vps15 is autophosphorylated (Herman et al., 1991a). However, it has also been 
speculated that Vps15 is a pseudokinase since it has nontypical residues in critical 
catalytic elements, including an HGD motif rather than HRD in the catalytic loop and a 
DFA motif instead of DFG for magnesium ion binding in the activation loop 
(Rostislavleva et al., 2015). Furthermore, Vps15 lacks an obvious ATP binding loop. 
 
More recently, Vps15 has been proposed to regulate Vps34 activity in part via changes 
in the contact of the Vps34 helical and kinase domains (HELCAT) with the Vps15 
pseudokinase domain (Stjepanovic et al., 2017). In the inactive conformation, the Vps34 
HELCAT domain contacts the Vps15 scaffold. During activation, the Vps34 HELCAT 
domain has been proposed to release contact with Vps15 and allow Vps34 to access its 
PI substrate (Figure 1.2). In support of this hypothesis, a ‘‘leashed’’ construct that 
prevented the HELCAT domain from releasing contact with Vps15 blocked Vps34 
enzyme activity in vitro (Stjepanovic et al., 2017). While it is clear that Vps15 acts as 
both a positive and negative regulator of Vps34 kinase function, many questions of the 
precise role Vps15 plays in regulating Vps34 remain. 
 
Vps34 and Vps15 act within at least two large regulatory complexes 
In addition to Vps34 and Vps15, PI 3-kinase activity is regulated by at least two large 
complexes. Vps34 and another regulator, Vps38, were identified as interactors of Vps30 
through pulldown of Vps30 and mass spectrometry of its interactors (Kihara et al., 
2001). Further analysis by immunoprecipitation of Vps30 and western blot revealed that 
Vps30 also interacts with Vps15 and a previously reported Vps30 interactor, Atg14 
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(Kametaka et al., 1998), suggesting that Vps30 acts as a member of at least one 
Vps34-Vps15 complex (Kihara et al., 2001). Further analysis revealed that 
immunoprecipitation of Atg14 pulled down Vps34, Vps15, and Vps30, but not Vps38, 
while immunoprecipitation of Vps38 pulled down Vps34, Vps15, and Vps30, but not 
Atg14. This result indicates that Vps38 and Atg14 are present in two different PI 3-
kinase complexes (Kihara et al., 2001). 
 
Consistent with Vps38 and Atg14 being part of separate complexes, phenotypic 
analysis revealed that while vps38D cells were deficient in CPY maturation and atg14D 
cells were deficient in autophagy and aminopeptidase I (API) maturation, vps30D, 
vps15D, and vps34D cells were deficient in all three processes (Kihara et al., 2001) 
(Figure 1.3). Thus, the Atg14-containing complex I is required for autophagy, while 
Vps38-containing complex II is required for CPY maturation. Vps38 and Atg14 are 
thought to specify the subcellular localization of the PI 3-kinase complexes. The 
localization of Vps34 and Vps30, but not Vps15, to autophagosomes is Atg14-
dependent, while the localization to puncta believed to be endosomes is Vps38-
dependent (Obara et al., 2006). 
 
More recently, immunoprecipitation of Vps34 and mass spectrometry of its interactors 
revealed a novel interactor, Atg38 (Araki et al., 2013). Immunoprecipitation of Atg38 and 
western blot revealed that Atg38 interacts with Vps34, Vps15, Vps30, and Atg14, but 
not Vps38, demonstrating that Atg38 is a member of complex I. In atg38D cells, Atg14 
still interacts with Vps30, but no longer interacts with Vps34 or Vps15, indicating that 
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Atg38 is required to hold complex I together (Araki et al., 2013). Complexes I and II are 
diagrammed in Figure 1.4. 
 
Structural insights into the PI 3-kinase complexes 
Our understanding of the shape and organization of the PI 3-kinase complexes has 
been bolstered by a 4.4 Å crystal structure of the yeast PI 3-kinase complex II 
(Rostislavleva et al., 2015). This structure has an overall Y-shape with the tips of both 
arms of the Y binding to a membrane. Vps34 and Vps15 are intertwined on one arm so 
that the pseudokinase domain of Vps15 interacts with the lipid-binding region of the 
Vps34 kinase domain, suggesting that this structure is of an inactive conformation of the 
complex. On the other arm, Vps30 and Vps38 form a parallel heterodimer and bind the 
membrane via the Vps30 BARA domain (Huang et al., 2012; Noda et al., 2012). In the 
middle, the Vps34 C2 domain is the keystone to the organization of the complexes, 
interacting with all of the complex II subunits. 
 
A lower resolution electron microscopy structural analysis of complex I without Atg38 
revealed that the PI 3-kinase complex adopts a number of conformations (Stjepanovic 
et al., 2017). The most common of these conformations closely resembles the 
conformation of the crystal structure of complex II. Electron microscopy also revealed a 
“dislodged” conformation that is proposed to be the active conformation of the complex 
(Stjepanovic et al., 2017). In this conformation, the HELCAT domain of Vps34 does not 
contact Vps15, which is believed to allow Vps34 to access its PI substrate (Figure 1.2). 
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Turnover of PI3P in yeast 
In yeast, the turnover of phosphoinositide lipids is controlled by a number of 
phosphoinositide phosphatases. These phosphatases fall broadly into two categories: 
those with homology to Sac1 (Guo et al., 1999; Hughes et al., 2000) and those with 
homology to myotubularin (Taylor et al., 2000). With the exception of Fig4, which 
specifically dephosphorylates the 5-position of PI(3,5)P2 in vitro (Rudge et al., 2004), 
phosphatases with homology to Sac1 appear to act on a number of phosphoinositide 
species (Guo et al., 1999; Hughes et al., 2000; Foti et al., 2001). The promiscuous 
nature of these Sac1 family phosphatases makes them difficult to study, as they are 
partially redundant with each other. Furthermore, it is difficult to attribute phenotypes 
observed in Sac1 family mutants to a change in just one phosphoinositide species. 
 
S. cerevisiae contain one phosphatase with homology to myotubularin, Ymr1. In vitro, 
Ymr1 specifically dephosphorylates PI3P to PI (Taylor et al., 2000). In cells, deletion of 
Ymr1 led to a modest ~15% increase in PI3P levels, though overexpression of Ymr1 on 
a 2µ plasmid led to a 25% decrease in PI3P levels (Parrish et al., 2004). Interestingly, 
when combined with deletion of a Sac1 family phosphatase, Sjl3 (Inp53), ymr1Dsjl3D 
cells accumulate approximately 2.5 times the PI3P present in wild-type cells with 
minimal changes to other phosphoinositides (Parrish et al., 2004). These cells exhibited 
a number of defects including vacuole fragmentation, along with defects in CPY, API, 
and carboxypeptidase S (CPS) maturation (Parrish et al., 2004). These results 
demonstrate the importance turnover of PI3P plays in regulating cell homeostasis. 
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PI3P regulates a number of downstream pathways in yeast 
The PI3P dependence of downstream processes is most often established by testing 
whether the process occurs in PI 3-kinase complex component knockouts, commonly 
Vps34. In many cases, the PI3P-dependence of a process has been attributed 
specifically to one of the two known PI 3-kinase complexes by testing whether the 
process is disrupted in Vps38 or Atg14 knockout cells. In this manner, a number of 
PI3P-dependent cellular processes have been identified in yeast (Figure 1.5). 
 
PI3P is converted into other PPI lipids 
Because PPI lipids are interconverted by phosphorylation and dephosphorylation, in 
mammalian systems, the production of PI3P can lead to downstream changes in a 
number of PPI lipid species. However, in a simplified yeast system, PI3P can only be 
phosphorylated at the 5-position to PI(3,5)P2 (Gary et al., 1998). Thus, Vps34 mutants 
that do not produce PI3P also do not produce PI(3,5)P2 (Dove et al., 1997). 
 
PI3P is required for multiple retrograde transport pathways 
Within the endocytic pathway, transport is thought of as moving towards the so-called 
terminal compartment, the vacuole. Multiple retrograde transport steps for movement 
away from the vacuole have been shown to require PI3P. The yeast retromer functions 
in retrograde transport of transmembrane sorting receptors from endosomes back to the 
Golgi (Seaman et al., 1997; Seaman et al., 1998). Defects in retromer function result in 
the aberrant delivery of Vps10, a yeast mannose-6 phosphate receptor, to the vacuolar 
membrane (Cooper and Stevens, 1996; Seaman et al., 1997). Vps10 acts as a sorting 
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receptor for the soluble vacuolar hydrolase, CPY (Westphal et al., 1996). Thus, when 
Vps10 is mislocalized to the vacuole, delivery of CPY to the vacuole is disrupted 
(Paravicini et al., 1992). Interestingly, the delivery of other soluble vacuolar hydrolases, 
PrA and PrB, to the vacuole is not affect by mutations in the retromer (Paravicini et al., 
1992), despite the fact that Vps10 also acts as a sorting receptor for both PrA (Westphal 
et al., 1996). This result suggests that other retrograde transport mechanisms may be 
involved in the delivery of PrA and PrB to the vacuole. 
 
Retromer function requires PI3P as PI3P recruits retromer components, Vps5 and 
Vps17 to membranes (Burda et al., 2002). Vps5 and Vps17 are sorting nexins that 
contain a BAR domain (SNX-BAR) that also contain PI3P-binding PX domains (Yu and 
Lemmon, 2001). These SNX-BAR proteins help to coordinate membrane deformation 
and cargo selection in vesicle formation (van Weering et al., 2010). vps34D, vps15D, 
vps30D, and vps38D cells all exhibit a defect in CPY maturation, indicating that PI 3-
kinase complex II is required for retromer function (Kihara et al., 2001). Interestingly, 
while Vps30 and Vps38 are not required for the maturation of PrA and PrB, Vps34 and 
Vps15 are required (Kihara et al., 2001) (Figure 1.3). These results suggest that 
Vps34/Vps15 maintain some functions independent of complexes I and II. Most likely, 
Vps34/Vps15 either maintain kinase function without other members of a kinase 
complex or function within an as yet uncharacterized third yeast PI 3-kinase complex. 
 
Until recently, retrograde transport from the vacuole had only been demonstrated for an 
artificial cargo, retention sequence-alkaline phosphatase (RS-ALP), which fused a 
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retromer retrieval signal to ALP (Pho8 in yeast) (Bryant et al., 1998). However, more 
recently, a SNX-BAR protein, Snx4, has been implicated in a retrograde transport 
pathway for retrieval of proteins from the vacuole to endosomes (Ma et al., 2017; Suzuki 
and Emr, 2018). Snx4 functions as a heterodimer with Snx41 or Atg20/Snx42 (Hettema 
et al., 2003). PI3P is required for proper Snx4 localization and is necessary for Snx4-
dependent retrograde transport (Nice et al., 2002; Suzuki and Emr, 2018). Atg27 is the 
first identified physiological substrate for Snx4-dependent retrograde transport from the 
vacuole and is also a client protein for retromer-dependent retrograde transport. 
Interestingly, there are conflicting reports on which Snx4 heterodimer is required for 
retrograde transport of Atg27. Some reports suggest that either the Snx4/Snx41 or 
Snx4/Snx42 can support retrograde transport of Atg27 (Suzuki and Emr, 2018), while 
others report that the Snx4/Snx41 heterodimer, but not the Snx4/Snx42 heterodimer 
can support retrograde transport of Atg27 (Ma et al., 2017). Following its synthesis, 
Atg27 is delivered from the Golgi to the vacuole via the AP-3 pathway (Segarra et al., 
2015). From the vacuole, Atg27 undergoes retrograde transport to endosomes in a 
Snx4-dependent manner (Ma et al., 2017; Suzuki and Emr, 2018). Finally, from 
endosomes, Atg27 undergoes retromer-dependent retrograde transport back to the 
Golgi (Suzuki and Emr, 2018). Due to the cyclic nature of its transport, changes in 
Atg27 localization can signify changes in the rates of these retrograde transport steps. 
For example, treatment with Rapamycin has been shown to induce transport of Atg27 
away from the vacuole in a Snx4-dependent manner (Ma et al., 2017). Similar to Atg27, 
RS-ALP is delivered to the vacuole in an AP-3-dependent manner (Bryant et al., 1998). 
Interestingly, unlike retrieval of Atg27 from the vacuole (Suzuki and Emr, 2018), retrieval 
 12 
of RS-ALP from the vacuole membrane requires PI(3,5)P2 (Bryant et al., 1998), 
suggesting that these two substrates undergo retrograde trafficking by distinct 
pathways. 
 
PI3P is required for ESCRT function 
Function of the endosomal sorting complexes required for transport (ESCRT) pathway 
also depends on PI3P. The multi-complex ESCRT machinery bends membranes away 
from the cytoplasm and plays important roles at endosomes in the biogenesis of multi-
vesicular bodies (MVBs) (reviewed in (Piper and Katzmann, 2007)). Transmembrane 
ESCRT client proteins are first ubiquitinated, which enables their recognition and 
binding to the ESCRT complex. Once the cargo proteins are bound, the ESCRT 
complex generates vesicles via inward budding into lumen of the organelle, and the 
cargoes are ultimately delivered to the vacuole. ESCRT is required for the delivery of 
the vacuolar hydrolase CPS to the vacuolar lumen (Odorizzi et al., 1998; Katzmann et 
al., 2001). Precursor CPS is a type-II transmembrane protein that moves through the 
secretory pathway to endosomes, where ubiquitination marks CPS for ESCRT-
dependent selective sorting into the invaginating vesicles of the MVB (Spormann et al., 
1992; Katzmann et al., 2001). When MVBs fuse with the vacuole, CPS is delivered to 
the vacuolar lumen and is cleaved by proteinase A to its mature form that is soluble 
within the vacuolar lumen. Defects in ESCRT function result in an inability to form MVBs 
and aberrant delivery of CPS to the vacuolar limiting membrane (Odorizzi et al., 1998). 
ESCRT-0 functions by binding ubiquitinated ESCRT client proteins and recruiting 
ESCRT-I to membranes. Vps34 is required for proper localization of the ESCRT-0 
 13 
subunit Vps27, which contains a PI3P-binding FYVE domain (Katzmann et al., 2003). 
Interestingly, Fab1, the PI3P 5-kinase, is also reported to be required for the delivery of 
CPS to the vacuolar lumen (Odorizzi et al., 1998), suggesting that PI(3,5)P2 may be 
involved in ESCRT function via an unknown mechanism. Surprisingly, neither Vps30 or 
Vps38 are required for the delivery of CPS to the vacuolar lumen (Burda et al., 2002), 
which may suggest that ESCRT function is a complex I and II-independent role for 
Vps34. More recently, ESCRT and PI3P have also been found to function directly on 
the vacuole, generating vesicles via inward budding into the vacuole lumen for the 
selective degradation of vacuole membrane proteins (Li et al., 2015; Zhu et al., 2017). 
 
PI3P in the fusion of vesicles to the vacuole 
Additionally, PI3P is required for fusion of vesicles with the vacuole, and homotypic 
vacuole fusion. This is due in part to the direct binding of the SNARE Vam7 (Cheever et 
al., 2001; Fratti and Wickner, 2007) and the heterodimeric GEF subunits Mon1 and 
Ccz1 (Cabrera et al., 2014) to PI3P. Moreover, Vps34-dependent generation of PI3P is 
required for the vacuole association of many additional proteins required for vacuole 
fusion (Lawrence et al., 2014). 
 
PI3P is required for multiple steps in autophagy 
It has long been known that defects in PI 3-kinase complex I block autophagy in yeast 
(Kihara et al., 2001). Early in autophagy, PI3P recruits Atg18 to the phagophore (Dove 
et al., 2004; Obara et al., 2008) where it interacts with Atg2 and tethers pre-
autophagosomal membranes to the endoplasmic reticulum, allowing Atg2 to transport 
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lipids to promote autophagosome biogenesis (Rieter et al., 2013; Kotani et al., 2018; 
Valverde et al., 2019). More recently, PI3P has also been implicated in later steps of 
autophagy. Following autophagosome formation, Ymr1, a myotubularin family protein 
and putative PI3P phosphatase (Taylor et al., 2000; Parrish et al., 2004) is crucial for 
autophagosome fusion with the vacuole. Deletion of YMR1 causes a failure of key 
autophagy machinery including Atg18 to dissociate from mature autophagosomes. This 
leads to accumulation of autophagosomes in the cytoplasm (Cebollero et al., 2012) and 
suggests that turnover of PI3P is crucial for this process. PI3P also has a positive role in 
a late step in autophagy. In vitro studies indicate that fusion of autophagosomes with 
the vacuole requires PI3P and likely acts by recruiting the Rab GTPase Ypt7, which in 
turn recruits the HOPS tethering complex (Bas et al., 2018). Thus, while PI3P is 
required for some steps in autophagy, impeding turnover of PI3P inhibits the resolution 
of autophagosomes. 
 
Cytoplasm-to-vacuole targeting (Cvt) is a constitutive and specific form of autophagy 
that uses autophagosome-like vesicles for selective transport of the vacuolar hydrolase 
API (Yoshihisa and Anraku, 1989; Klionsky et al., 1992; Harding et al., 1996). While 
much of the autophagy machinery also functions in CVT, some autophagy proteins are 
dispensable for CVT and vice-versa (Harding et al., 1996). While PI 3-kinase complex I 
is required for both processes (Kihara et al., 2001) (Figure 1.3), PI3P has been 
proposed to have different functions in autophagy and CVT. Atg27 was identified as a 
PI3P-binding protein that binds to PI3P via a basic KKPAKK motif. Mutation of this motif 
blocked CVT function, but had much more minor effects on autophagy (Wurmser and 
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Emr, 2002). However, because of a sequencing error, the true amino acid sequence of 
Atg27 contains an additional 75 amino acids at the N-terminus. These additional amino 
acids mean that rather than being a type II transmembrane protein as previously 
reported (Wurmser and Emr, 2002), Atg27 is a type I transmembrane protein (Yen et 
al., 2007). This means that the proposed PI3P binding site in full length Atg27 would not 
be exposed to the cytosolic side of the membrane. Furthermore, full length Atg27 did 
not require PI3P for correct localization nor did it require the KKPAKK motif (Yen et al., 
2007). Additionally, the KKPAKK motif was found to be dispensable for CVT and 
autophagy function (Yen et al., 2007). Together, these results suggest that binding PI3P 
is not required for Atg27 function. 
 
PI3P plays a poorly understood role in pheromone signaling 
vps34D and vps15D cells, but not vps30D, vps38D, or atg14D cells exhibit a defect in 
pheromone signaling (Slessareva et al., 2006). Vps34 and Vps15 both bind directly to 
Gpa1, a G protein alpha subunit involved in pheromone response, with Vps15 binding 
preferentially to unactivated Gpa1 and Vps34 preferentially binding activated Gpa1 
(Slessareva et al., 2006). Interestingly, expression of a constitutively active Gpa1 allele, 
Gpa1-Q323L leads to increased production of PI3P (Slessareva et al., 2006), one of the 
few known methods of elevating PI3P levels in yeast. These results are consistent with 
Gpa1 stimulating Vps34 PI 3-kinase activity. It still remains unclear, however, how 
Vps34 modulates pheromone responsiveness. It is unlikely that this pheromone 
responsiveness phenotype is due to a defect in membrane trafficking, as other Vps 
mutants do not exhibit defects in pheromone signaling (Slessareva et al., 2006). 
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Poorly understood phenotypes of vps34D cells 
vps34D cells exhibit phenotypes that aren’t completely explained by the known function 
of Vps34. Vps34 was identified in a screen for growth sensitivity on plates containing 
ethanol (Takahashi et al., 2001). The same study found that Vps34 and the other 
identified ethanol sensitive mutants also exhibited sensitivity to Calcofluor white and 
Zymolyase, indicative of a defect in cell wall integrity (Takahashi et al., 2001). Ethanol 
sensitivity is correlated with temperature sensitivity (Aguilera and Benitez, 1986) and 
vps34D cells are also known to have a growth defect at 37°C (Herman and Emr, 1990; 
Takahashi et al., 2001). Interestingly, while vps34D and vps15D cells exhibit a growth 
defect at 37°C, vps30D, vps38D, and atg14D cells do not (Kihara et al., 2001) (Figure 
1.3). These defects in cell wall integrity and ethanol and temperature-sensitivity are not 
easily explained by the known function of Vps34 and may potentially point to a complex 
I and II-independent role for Vps34/Vps15. Overall, while much is known about the roles 
that PI3P plays in yeast, much still remains to be discovered. Here, I focus on 





Figure 1.1: Interconversion of PPIs by PPI kinases and phosphatases in mammals 
and yeast. PPIs are generated by the action of phosphoinositide kinases and 
phosphatases in mammals (left) and yeast (right). These reactions are confined to 
membrane subdomains where these phosphoinositide modifying enzymes reside 
(reviewed in (Strahl and Thorner, 2007; Sasaki et al., 2009; Balla, 2013; Shisheva et al., 
2015; Wallroth and Haucke, 2018; Dickson and Hille, 2019)). These reactions yield 
mono-phosphates (phosphatidylinositol-3-phosphate (PI3P), phosphatidylinositol-4-
phosphate (PI4P), phosphatidylinositol-5-phosphate (PI5P)), bis-phosphates 
(phosphatidylinositol-3,4-bisphosphate (PI3,4P2), phosphatidylinositol-3,5-bisphosphate 
(PI(3,5)P2), phosphatidylinositol-4,5-bisphosphate (PI4,5P2)), and tris-phosphate 

































































































































Figure 1.2: A model of Vps34 activation. Vps34 is proposed to be regulated in part 
via changes in contact of the Vps34 HELCAT domain with Vps15. In the inactive 
conformation, the Vps34 HELCAT domain contacts the Vps15 scaffold. During 
activation, the Vps34 HELCAT domain is proposed to alter the contact with Vps15 and 





Figure 1.3: Summary of the phenotypes observed in cells with PI 3-kinase 
complex proteins knocked out. PI 3-kinase complex proteins were knocked out 
individually and tested for a number of phenotypes including vacuolar delivery and 
maturation of Aminopeptidase I (API), carboxypeptidase Y (CPY), and Proteinase A and 
B (PrA and PrB). Additionally, autophagy was assessed by measuring the autophagy-
dependent processing of alkaline phosphatase Pho8D60 (Noda et al., 1995). The ability 






Figure 1.4: Schematic illustrating the two known PI 3-kinase complexes in yeast 
and their functions. Vps34 acts in at least two large regulatory complexes. Vps15, a 
member of both complexes is absolutely required for PI3P synthesis. In addition to 
Vps34 and Vps15, both known complexes contain Vps30. Complex I, which includes 
Atg14 and Atg38, is required for autophagy, whereas complex II, which includes Vps38, 




Figure 1.5: Schematic indicating several PI3P-dependent intracellular trafficking 
pathways in yeast. PI3P serves as the substrate for PI(3,5)P2. PI3P is also required for 
Snx4-dependent retrograde transport from the vacuole and retromer-dependent 
retrograde transport from endosomes. ESCRT function at late endosomes and the 
vacuole is also dependent on PI3P. Furthermore, PI3P is required for phagophore 
formation during the initiation of autophagy. PI3P is then removed prior to the 
disassembly of some autophagy proteins from the surface of mature autophagosomes. 
In addition, fusion of autophagosomes and other vesicles with the vacuole, as well as 
homotypic vacuole fusion (not shown), are PI3P-dependent pathways. PI3P also plays 
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Elevating PI3P Drives Select Downstream  
Membrane Trafficking Pathways2 
 
Introduction 
Phosphoinositide (PPI) lipids are signaling molecules that play critical roles in multiple 
cellular processes. Most studies of how PPI lipids regulate downstream pathways use 
knockout or knockdown of PPI kinases to deplete a specific PPI lipid and thereby test 
the necessity for that PPI species in a process (Kihara et al., 2001). However, there are 
very few reports on the impact of elevating phosphoinositides. Understanding the 
impact of elevating phosphoinositides is critical as the levels of PPI lipids are 
dynamically regulated by PPI lipid kinases and phosphatases in response to stimuli 
(Balla, 2013). For example, during hyperosmotic shock in S. cerevisiae, there is a 
transient 15 to 20-fold elevation in phosphatidylinositol-3,5-bisphosphate (PI(3,5)P2) 
(Duex et al., 2006a). The dynamic regulation of PPI lipids suggests that in addition to 




2 This chapter is adapted from a published paper: Steinfeld, N., Lahiri, V., Morrison, A., Metur, S.P., 
Klionsky, D.J., and Weisman, L.S. (2021). Elevating PI3P drives select downstream membrane trafficking 
pathways. Mol Biol Cell 32, 143-156. 
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Here, we test this hypothesis directly by manipulating the levels of phosphatidylinositol 
3-phosphate (PI3P), which is dynamically regulated in yeast (Duex et al., 2006a). We 
report the generation and use of hyperactive mutations in Vps34 and the discovery that 
PI3P drives select pathways, including synthesis of PI(3,5)P2 during hyperosmotic 
shock and retrograde transport of Atg27. In these cases, the PI3P-dependent step is 
rate limiting. We also show that hyperactive Vps34 does not affect ESCRT function at 
endosomes or on the vacuole. Thus, elevating PI3P does not always increase the 
overall rate of a complex pathway. We also show that elevating PI3P can delay a 
pathway. Hyperactive Vps34 does not affect the induction of autophagy, but inhibits late 
steps in autophagy, in part via a delay in disassembly of the autophagy machinery from 
the surface of mature autophagosomes and also a delay in fusion of autophagosomes 
with the vacuole. This latter defect is likely due to a more general defect in vacuole 
fusion, as evidenced by an increase in the number of vacuole lobes per cell, which is 
consistent with a defect in homotypic vacuole fusion. Overall, our studies suggest that 
stimulus-induced elevation of PI3P regulates some, but not all, PI3P-dependent 
membrane trafficking pathways and that phosphoinositide lipids are commonly rate-
limiting in pathways where they are required. 
 
Results and Discussion 
Generation of hyperactive Vps34 mutants 
To test the hypothesis that changes in PPI levels drive downstream processes, we 
devised a strategy for specifically elevating PI3P. PI3P was an attractive target because 
several downstream PI3P-dependent processes have been identified in yeast (Figure 
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2.1A). Additionally, the existing 4.4 Å crystal structure of the yeast PI 3-kinase complex 
allowed us to predict amino acid changes that would increase PI3P levels (Rostislavleva 
et al., 2015). Moreover, the crystal structure also allowed us to map the location of 
amino acid changes responsible for the hyperactivity of the Vps34 mutants identified in 
our screen. 
 
We found that overexpression of Vps34 alone or together with Vps15 caused a modest, 
13%, increase in PI3P levels despite robust overexpression (Figure 2.2A and B). This 
result suggests either that overexpression of additional subunits of the Vps34 complex 
are required for increased Vps34 function or that Vps34 kinase activity is negatively 
regulated. 
 
To achieve more robust elevation of PI3P levels, we tested whether point mutations in 
Vps34 would yield a hyperactive enzyme. Vps34 activity is proposed to be regulated in 
part via changes in the contact of the Vps34 helical and kinase domains (HELCAT) with 
the Vps15 pseudokinase domain (Figure 2.1B) (Stjepanovic et al., 2017). In the inactive 
conformation, the Vps34 HELCAT domain contacts the Vps15 scaffold. During 
activation, the Vps34 HELCAT domain is proposed to alter its contact with Vps15 and 
allow Vps34 to access its PI substrate. Based on the structure of the PI 3-kinase 
complex, we introduced point mutations in Vps34 along its contact site with Vps15 
(Figure 2.2C). We tested eight Vps34 point mutants and identified two mutations, 
R283E and A287D, that robustly increased PI3P by 36 and 27%, respectively (Figure 
2.2D). 
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Combining R283E and A287D, but not other mutations along the Vps34 HELCAT-
Vps15 interface, elevated PI3P levels by approximately 40% (Figure 2.2E). These two 
mutants are on an alpha-helix N-terminal to the helical domain of Vps34 and face Vps15 
(Figure 2.1C). Identification of these hyperactive Vps34 mutants provides further 
evidence that altered contact between the Vps34 HELCAT domain and Vps15 promotes 
Vps34 kinase activity. 
 
We also performed an unbiased genetic screen for hyperactive Vps34 mutants using a 
method similar to one used to generate hyperactive mutations in the PI3P 5-kinase, 
Fab1 (Duex et al., 2006b; Lang et al., 2017). We generated a hypomorphic Vps34-
K759D allele, which has a mutation in the activation loop of Vps34 and found that it 
lowers PI3P levels to approximately 20% of wild-type Vps34. We then performed 
random PCR mutagenesis on the C-terminal half of Vps34-K759D (Figure 2.3A). 
Mutagenized plasmids were tested for their ability to rescue growth in vps34D cells 
grown on rapamycin at 33°C. From 22 independently isolated mutants, we identified 
nine unique point mutations. Five of these mutations elevate PI3P levels. The best of 
these mutations, Y501C, elevated PI3P approximately 40% (Figure 2.1C, 2.3C). 
Interestingly, each of the five mutated residues are located on either the alpha-C helix of 
the Vps34 kinase domain or an adjacent helix of the helical domain (Figure 2.3B). 
Conformational changes in the alpha-C helix are critical for regulating kinase function 
(Taylor et al., 2015). We hypothesize these hyperactive mutants favor an active 
conformation of the alpha-C helix. It is not known whether these are regulatory sites on 
the native enzyme. We determined that combining the R283E and A287D mutant with 
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Y501C (Vps34-EDC) elevates PI3P by approximately 60%, which is higher than either 
mutant alone (Figure 2.1D). The Vps34-EDC mutant does not change Vps34 protein 
levels (Figure 2.4A and B), nor does it change the localization of Vps34 within the cell 
as measured by the amount of Envy-Vps34 that co-localizes with the vacuole (Figure 
2.4C and D). This suggests that the distribution of PI3P in the cell is most likely 
unchanged by the hyperactive mutant. 
 
PI3P is the substrate for the PI3P 5-kinase Fab1, which generates PI(3,5)P2 (Gary et al., 
1998). We tested whether elevation of PI3P via hyperactive Vps34 leads to an elevation 
of PI(3,5)P2. At basal conditions, no statistically significant increase in PI(3,5)P2 levels 
was detected (Figure 2.1E). However, when hyperosmotic shock was used to induce a 
transient elevation of PI(3,5)P2 (Duex et al., 2006a), the presence of hyperactive Vps34 
mutants resulted in further elevation of PI(3,5)P2 (Figure 2.1F). Note that while PI3P 
levels decrease during hyperosmotic shock, hyperactive Vps34 mutants still elevate 
PI3P above wild-type levels (Figure 2.3D). Thus, hyperactive Vps34 drives elevation of 
PI(3,5)P2 during hyperosmotic shock. We ruled out several potential mechanisms by 
which hyperactive Vps34 might elevate PI(3,5)P2. We determined that hyperactive 
Vps34-EDC does not change the amount of Fab1-Envy that co-localizes with the 
vacuole (Figure 2.5A and B). Additionally, there was no change in the amount of Fab1 
complex member Fig4 (Botelho et al., 2008) that colocalizes with the vacuole (Figure 
2.5C and D). These results suggest that hyperactive Vps34 does not result in increased 
recruitment of the Fab1 complex to membranes. Moreover, the increase in PI(3,5)P2 is 
likely not due to inhibition of Fig4, the PI(3,5)P2 5-phosphatase (Gary et al., 2002). 
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Catalytically dead Fig4 mutants exhibit a mild increase in PI(3,5)P2 under basal 
conditions, yet a decrease in PI(3,5)P2 at 10 min following hyperosmotic shock (Duex et 
al., 2006b; Strunk et al., 2020). Thus, the increase in PI(3,5)P2 caused by Vps34-EDC 
most likely occurs because of increased availability of PI3P, which may provide more 
substrate for Fab1 and/or activate Fab1. Note that the additional PI(3,5)P2 provided 
during hyperosmotic shock by hyperactive Vps34-EDC does not affect the growth of 
yeast cells following hyperosmotic shock (Figure 2.5E). 
 
Hyperactive Vps34 increases retrograde transport of Atg27 
Atg27 is a cargo for PI3P-dependent Snx4- and retromer-dependent retrograde 
transport. Following its synthesis, Atg27 is delivered from the Golgi to the vacuole via 
the AP-3 pathway (Segarra et al., 2015). From the vacuole, Atg27 undergoes retrograde 
transport to endosomes in a Snx4-dependent manner (Ma et al., 2017; Suzuki and Emr, 
2018). From endosomes, Atg27 undergoes retrograde transport back to the Golgi via 
the retromer (Suzuki and Emr, 2018). Due to the cyclic nature of its transport, changes 
in Atg27 localization signify changes in the rates of each of these transport steps. 
 
We tested whether hyperactive Vps34 increases the rate of retrograde transport of 
Atg27 from the vacuole to endosomes and/or Golgi. In wild-type cells, Atg27-2xGFP 
was primarily localized to the vacuole (Figure 2.6A) with a few Golgi (Figure 2.6D) and 
endosomal (Figure 2.6F) puncta. Notably, in the presence of Vps34-EDC, Atg27-2xGFP 
was more punctate (Figure 2.6A) and fewer hyperactive Vps34-EDC cells had Atg27-
2xGFP visible on the vacuole (Figure 2.6B). Moreover, on a per cell basis, less Atg27-
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2xGFP colocalized with the vacuole (Figure 2.6C). Blocking retrograde transport from 
the vacuole by deletion of SNX4 suppressed Atg27-2xGFP traffic from the vacuole 
(Figure 2.6A-C). These results suggest that hyperactive Vps34-EDC accelerates the 
Snx4 and/or retromer pathways. 
 
The loss of Atg27-2xGFP localization to the vacuole is likely not caused by impairment 
of the AP-3-dependent anterograde delivery of Atg27 to the vacuole. We tested the 
localization of another AP-3 client protein Yck3 (Sun et al., 2004) and found that it was 
delivered to the vacuole in the presence of Vps34-EDC (Figure 2.7A), indicating that 
Vps34-EDC does not cause a defect in AP-3 function. 
 
We tested whether the additional Atg27-2xGFP puncta present in Vps34-EDC 
correspond to Golgi and/or endosomes. We found that expression of Vps34-EDC 
resulted in a higher percentage of the total cellular Atg27-2xGFP that colocalizes with 
the Golgi marker, Sec7-mCherry (Figure 2.6D and E). There was no statistically 
significant difference between Vps34-EDC-expressing cells compared to wild-type with 
respect to the total cellular Atg27-2xGFP signal that colocalized with endosome marker 
Vps8-mCherry (Figure 2.6F and G). Accumulation of Atg27-2xGFP in the Golgi is 
consistent with the hypothesis that hyperactive Vps34-EDC leads to increases in both 
Snx4- and retromer-dependent retrograde transport of Atg27. 
 
We tested whether deletion of the retromer subunit VPS35 suppresses the increased 
Atg27-2xGFP localization to the Golgi caused by Vps34-EDC. Consistent with the 
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retromer being required for accelerated retrograde transport of Atg27, in vps35∆ cells, 
there was no difference in Atg27-2xGFP localization to the Golgi between wild-type 
Vps34 and Vps34-EDC (Figure 2.7B and C). However, surprisingly, vps35∆ cells 
exhibited increased localization of Atg27-2xGFP to the Golgi compared to wild-type 
cells. This result was unexpected since a previous study reported that Atg27 
accumulates on endosomes in vps35∆ cells with less Atg27 on Golgi (Suzuki and Emr, 
2018), which fits with the view that the retromer functions in retrograde traffic of proteins 
from endosomes to the Golgi. However, this previous study is complicated by the fact 
that experiments were performed following 1 h of treatment with rapamycin. Because 
rapamycin inhibits protein synthesis in yeast (Barbet et al., 1996), we reasoned that 
rapamycin treatment may have masked a defect in AP-3-dependent anterograde 
delivery of Atg27 to the vacuole, leading to accumulation of Atg27 in the Golgi. 
However, deletion of VPS35 does not appear to affect AP-3 function, as another AP-3 
client protein Yck3 is delivered to the vacuole in vps35∆ cells (Figure 2.7D). Thus, under 
basal conditions, trafficking of Atg27 in vps35∆ cells is more complex than previously 
appreciated. Together, these results suggest that, in yeast, elevating PI3P drives 
retrograde transport from the vacuole, and leaves open the possibility that retrograde 
traffic from endosomes to the Golgi is accelerated as well.  
 
Hyperactive Vps34 does not affect ESCRT-dependent degradation of amino acid 
transporters Ypq1 or Mup1 
ESCRT function is regulated by PI3P and plays a crucial role in trafficking select 
transmembrane proteins to the vacuole for degradation, including the vacuolar cationic 
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amino acid transporter Ypq1 (Li et al., 2015; Zhu et al., 2017). Following withdrawal of 
lysine, Ypq1 is ubiquitinated and internalized inside the vacuole by the ESCRT 
machinery where it is degraded. 
 
Using western blot analysis, we tested whether hyperactive Vps34-EDC accelerates 
ESCRT-dependent degradation of Ypq1 following withdrawal of lysine by measuring 
Ypq1-GFP levels normalized to Vph1. We found that degradation of Ypq1-GFP was not 
affected by Vps34-EDC (Figure 2.8A and B), suggesting that elevating PI3P does not 
affect ESCRT function in the degradation of Ypq1. 
 
We also tested a second ESCRT substrate, the plasma membrane methionine 
transporter Mup1 (Teis et al., 2008). Mup1 accumulates on the plasma membrane when 
cells are starved for methionine. When methionine is reintroduced to cells, Mup1 is 
ubiquitinated, endocytosed, delivered to endosomes, and internalized by ESCRT into 
multi-vesicular bodies, which then fuse with the vacuole where Mup1 is degraded 
(Menant et al., 2006; Teis et al., 2008). Thus, to test ESCRT function, we measured 
Mup1-GFP levels normalized to Pgk1 following re-addition of methionine. 
 
Similar to what was observed with Ypq1, there were no statistically significant 
differences in the rate of Mup1 degradation between wild-type and hyperactive Vps34-
EDC following re-addition of methionine (Figure 2.8C and D). The half-life of Mup1-GFP 
following re-addition of methionine was calculated to be 33.7 min (SEM 2.39 min) with 
wild-type Vps34, and 30.8 min (SEM 2.61 min) with Vps34-EDC. This experiment 
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indicates that elevating PI3P does not affect ESCRT function in the degradation of 
Mup1. Overall, in contrast to the retrograde transport of Atg27, elevating PI3P does not 
accelerate ESCRT function on the vacuole or endosomes, demonstrating that elevating 
PI3P does not always increase the overall rate of a complex pathway. 
 
Hyperactive Vps34 inhibits a late step in autophagy 
PI3P is involved in multiple steps of autophagy, including autophagosome biogenesis, 
disassembly of the autophagy machinery from the surface of mature autophagosomes, 
and the fusion of mature autophagosomes with the vacuole. As part of our analysis, we 
investigated each of these steps. A combination of autophagy induction and flux was 
assessed by determining the levels of lipidated Atg8 (Atg8–PE) (Klionsky et al., 2016). 
Atg8 (LC3 and GABARAP subfamilies in mammals) is a ubiquitin-like protein. The 
expression of ATG8 is strongly induced after autophagy induction, following which Atg8 
is conjugated to phosphatidylethanolamine (PE) on the phagophore membrane 
(Ichimura et al., 2000). Following phagophore expansion and closure and before 
autophagosome-vacuole fusion, Atg8–PE on the cytoplasmic surface of the resulting 
autophagosome is cleaved from the membrane. The lumenal surface of the 
autophagosome, however, contains Atg8–PE that is trapped within the autophagosome. 
This pool of Atg8–PE can be monitored as autophagic cargo because, following fusion 
with the vacuole, this pool of Atg8–PE is degraded in the vacuolar lumen. 
Consequently, the steady-state level of Atg8–PE after autophagy induction is a function 
of both its generation and its degradation in the vacuole. 
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Treating cells with the serine protease inhibitor PMSF blocks the vacuolar degradation 
of Atg8–PE, facilitating the measurement of autophagy induction independent of Atg8–
PE turnover. Following 1 h of autophagy stimulation by nitrogen starvation, no 
difference in Atg8–PE levels could be detected between strains expressing Vps34-WT 
and Vps34-EDC in the presence of PMSF (Figure 2.9A and B), suggesting that the 
extent of autophagy induction was unchanged by hyperactive Vps34-EDC. Similarly, in 
the presence of PMSF, no difference in Atg8–PE levels could be detected between 
strains expressing Vps34-WT and Vps34-EDC at either 15 or 30 min following nitrogen 
starvation (Figure 2.9C and D). These results suggest that autophagy initiation requires, 
but is not driven by PI3P. 
 
As a second independent measure of the induction of autophagy, we investigated the 
transcriptional upregulation of critical autophagy genes, ATG1, ATG7, and ATG9, 
whose expression is elevated during nitrogen starvation (Delorme-Axford and Klionsky, 
2018). We found no differences in mRNA levels between Vps34-WT and Vps34-EDC 
following 30 min of nitrogen starvation (Figure 2.10A), suggesting that hyperactive 
Vps34 does not affect the transcription of autophagy genes. 
 
Whereas the levels of Atg8–PE are very similar between Vps34-WT and Vps34-EDC 
following starvation in the presence of PMSF, comparing Atg8–PE levels in the absence 
of PMSF reveals that Vps34-EDC partially blocks autophagy flux. In the absence of 
PMSF, degradation of Atg8–PE can occur after autophagosome fusion with the vacuole. 
Following 1 h of nitrogen starvation in the absence of PMSF, Atg8–PE protein levels 
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were markedly lower in Vps34-WT compared to Vps34-EDC (Figure 2.9A and B). The 
observation that no difference in Atg8–PE levels were detected between Vps34-WT and 
Vps34-EDC in the presence of PMSF, but that Atg8–PE was lower in Vps34-WT in the 
absence of PMSF, indicates that hyperactive Vps34 partially inhibits vacuolar delivery 
and degradation of Atg8–PE. 
 
To further characterize the defect in a late step of autophagy, we examined the 
dynamics of autophagosome biogenesis using GFP-tagged Atg8 as a marker. 
Hyperactive Vps34-EDC results in an increased number of GFP-Atg8 puncta in cells 
following 30 min of nitrogen starvation (Figure 2.10B and C). This result is consistent 
with either an increase in the induction of autophagy and/or with the inhibition of a late 
step in autophagy. Using time-lapse microscopy of GFP-Atg8 puncta, we measured the 
lifetime of GFP-Atg8 puncta in strains expressing either Vps34-WT or Vps34-EDC. 
GFP-Atg8 puncta in the presence of Vps34-WT persisted for 9 min, consistent with 
previous studies (Cebollero et al., 2012). In contrast, GFP-Atg8 puncta in the presence 
of Vps34-EDC persisted for 13.5 min (Figure 2.9E and F). These results suggest that 
the resolution of autophagosomes is delayed by hyperactive Vps34. Further evidence of 
this inhibition is observed by measuring the degradation of GFP-Atg8 via the 
appearance of proteolytically resistant free GFP by immunoblot analysis. Expression of 
hyperactive Vps34-EDC resulted in a reduction in the appearance of free GFP following 




To explore whether yet higher elevation of PI3P levels would further reduce autophagy 
flux, we enhanced the elevation of PI3P by combining the Vps34-EDC mutant with a 
knockout of the YMR1 gene, encoding a putative PI3P phosphatase. We found that the 
Vps34-EDC ymr1D mutant elevated PI3P by 105%, compared to 53% by Vps34-EDC 
alone and 28% by a ymr1D mutant alone (Figure 2.11C). Deletion of YMR1 in our strain 
background more robustly elevated PI3P levels than previously reported (Parrish et al., 
2004), and the increase in PI3P levels caused by YMR1 deletion was more evident in 
the presence of Vps34-EDC. Notably, the double Vps34-EDC ymr1D mutant inhibited 
autophagy flux considerably more than either mutation alone as measured by 
degradation of GFP-Atg8 by immunoblot analysis (Figure 2.11A and B). These results 
strongly indicate an inverse correlation between autophagy flux and an increase in 
cellular PI3P. Furthermore, the turnover of PI3P on autophagosomes may be critical for 
the successful completion of a late step in autophagy. 
 
Prior to the fusion of mature autophagosomes with the vacuole, some autophagy 
proteins, including the PI3P-binding protein Atg18, must be removed from the 
autophagosome surface (Cebollero et al., 2012). Removal of proteins from the surface 
of autophagosomes likely requires depletion of PI3P via the PI3P phosphatase Ymr1 
(Cebollero et al., 2012). Conversely, in vitro studies suggest that PI3P is required for the 
fusion of the autophagosome with the vacuole (Bas et al., 2018). Thus, we tested 
whether the expression of hyperactive Vps34-EDC had an impact on the displacement 




To specifically test displacement of Atg18 from the autophagosome surface 
independent of autophagosome-vacuole fusion, we blocked autophagosome-vacuole 
fusion by deleting the vacuolar t-SNARE Vam3 (Cebollero et al., 2012). We assessed 
the disassembly of Atg18 after 1 h of nitrogen starvation, by determining the percentage 
of GFP-Atg8-positive autophagosomes that colocalized with surface Atg18-RFP. In 
vam3D cells, hyperactive Vps34-EDC leads to a 10% increase in the percentage of 
GFP-Atg8 puncta that colocalize with Atg18-RFP (Figure 2.11D and E). This result 
suggests that hyperactive Vps34-EDC leads to a defect in the dissociation of autophagy 
proteins from mature autophagosomes. 
 
We also tested whether there was a defect in autophagosome fusion with the vacuole in 
a strain with wild-type Vam3. After 1 h of nitrogen starvation we measured the 
percentage of GFP-Atg8-positive autophagosomes that colocalize with Atg18-RFP. In 
this experiment, both disassembly of Atg18-RFP from the autophagosome surface and 
autophagosome-vacuole fusion can occur. A defect in autophagosome-vacuole fusion 
will result in the persistence of GFP-Atg8 puncta that do not colocalize with Atg18-RFP, 
and thus a decrease in the colocalization between GFP-Atg8 and Atg18-RFP. Indeed, 
we found that hyperactive Vps34-EDC caused a 9% decrease in the percentage of 
GFP-Atg8 puncta that colocalize with Atg18-RFP (Figure 2.11D and E). Note that the 
10% defect in disassembly of Atg18-RFP from autophagosomes that was observed in 
the vam3D cells likely also occurs in the wild-type VAM3 strain. Thus, this result 
suggests that Vps34-EDC leads to an approximately 20% defect in fusion of 
 44 
autophagosomes with the vacuole. Additionally, the total number of GFP-Atg8 puncta 
observed in vam3D cells did not change between wild-type and hyperactive Vps34-EDC 
(Figure 2.10D). Because autophagosomes are not turned over in vam3D cells, this 
result provides further evidence that hyperactive Vps34-EDC does not affect the 
induction of autophagy, indicating that differences in autophagy induction are not 
responsible for changes in the colocalization of GFP-Atg8 and Atg18-RFP. Note that 
Atg18 protein levels were not different between wild-type and Vps34-EDC under 
nutrient-rich conditions or following nitrogen starvation (Figure 2.10E and F). 
 
Together, our results suggest that whereas hyperactive Vps34-EDC has no effect on 
the induction of autophagy, it results in a decrease in autophagic flux in part via defects 
in both disassembly of the autophagy machinery from the surface of mature 
autophagosomes and fusion of autophagosomes with the vacuole. However, the 10% 
defect in disassembly of autophagy proteins from autophagosomes and the 20% defect 
in autophagosome-vacuole fusion do not fully account for the observed defect in 
autophagic flux. Autophagic flux, as measured by Atg8–PE levels, lifetime of Atg8 
puncta, or degradation of GFP-Atg8 indicated a defect in the range of 50-70%. Thus, 
there are likely additional steps in the resolution of autophagy that are affected by 
hyperactive Vps34-EDC. Interestingly, despite inhibiting autophagy, hyperactive Vps34-
EDC does not affect the survival of yeast cells during long-term nitrogen starvation 
(Figure 2.10G), which suggests that Vps34-EDC cells maintain sufficient levels of 
autophagy function to allow for survival during chronic nitrogen starvation. 
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The finding that hyperactive Vps34-EDC causes a partial defect in autophagosome 
fusion with the vacuole, raises the possibility that there is a more global defect in fusion 
with the vacuole. A defect in vacuole-vacuole fusion would result in a more fragmented 
vacuole morphology. To assess homotypic vacuole fusion, we counted the number of 
vacuole lobes per cell, finding a small but significant 12% increase in vacuole lobes 
(Figure 2.12A-B). This difference was predominantly due to an approximately 40% 
decrease in the number of cells with a single vacuole (Figure 2.12C). While an increase 
in the number of vacuole lobes per cell could also be caused by an increase in vacuole 
fission, a modest impairment of fusion fits closely with the observed defect in 
autophagosome fusion with the vacuole. 
 
Conclusions 
Most studies of PPI lipids use knockdown, knockout, or drug inhibition of PPI kinases to 
test whether a specific PPI is essential for a pathway. However, this approach does not 
indicate whether a PPI lipid is a key regulator of the pathway of interest. The ability to 
generate mutations that robustly elevate a PPI lipid provides an effective tool to 
elucidate the regulatory roles of PPI lipids. The major advantage of the Vps34-EDC 
mutant was that it enabled specific and direct testing of the downstream effects of 
elevating PI3P. It should be noted that in these experiments, the Vps34-EDC plasmid is 
constitutively expressed and thus PI3P is constitutively elevated. This is in contrast with 
wild-type cells where stimulus-induced changes in phosphoinositides occur on the order 
of minutes (Duex et al., 2006a). Cells may respond differently to chronic versus acute 
elevation of phosphoinositides. We determined that elevation of PI3P drives some 
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pathways, including synthesis of PI(3,5)P2 during hyperosmotic shock, as well as 
retrograde transport of Atg27. These findings demonstrate that elevation of PI3P drives 
some downstream processes and that in these cases, the PI3P-dependent step is rate 
limiting. In contrast, hyperactive Vps34 does not affect ESCRT function, demonstrating 
that elevating PI3P does not always increase the overall rate of a complex pathway. 
Much like ESCRT function, induction of autophagy is not accelerated by hyperactive 
Vps34, though, conversely, autophagic flux is lowered by hyperactive Vps34, in part by 
delaying disassembly of the autophagy machinery from the surface of mature 
autophagosomes as well as a delay in fusion of autophagosomes with the vacuole. 
These results provide evidence that PI3P can also inhibit specific steps within a 
pathway. Thus, these studies suggest that stimulus-induced elevation of PI3P can 
positively or negatively regulate some PI3P-dependent membrane trafficking pathways, 
and that phosphoinositide lipids are commonly rate-limiting in pathways where they are 
required. Moreover, these findings suggest that stimulus-induced elevation of PPI lipids 
provides a way for stimuli to selectively regulate pathways. 
 
It is interesting to speculate on the reasons that elevating PI3P differentially impacts 
PI3P-dependent pathways. Because hyperactive Vps34-EDC does not appear to affect 
the localization of Vps34 within the cell, it is unlikely that these differential effects are 
caused by differences in the subcellular distribution of PI3P. We had initially 
hypothesized that elevating PI3P would drive downstream PI3P-dependent pathways by 
enhancing the recruitment of PI3P-binding proteins to membrane subdomains and/or 
increasing substrate availability, thus allowing downstream processes to occur more 
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rapidly. However, as observed in some pathways, elevating PI3P sometimes does not 
affect the rate of a process. One possibility is that wild-type PI3P levels are sufficient to 
saturate a process, allowing for the recruitment of all the molecules of a PI3P-binding 
protein to a membrane subdomain or to provide an enzyme with sufficient substrate. 
The production of PI(3,5)P2 appears to fit this model. When Fab1 is activated during 
hyperosmotic shock, hyperactive Vps34 resulted in elevated production of PI(3,5)P2, 
likely due to increased PI3P substrate availability. However, when Fab1 is not as active 
at basal conditions, PI(3,5)P2 levels are not significantly increased by hyperactive 
Vps34, suggesting that wild-type PI3P levels are sufficient to provide Fab1 with enough 
substrate to produce PI(3,5)P2. It is also possible that within a complicated multi-step 
process, PI3P may act in a step that is not rate limiting. In the ESCRT pathway related 
to PI3P-dependent degradation of Mup1, it is possible that elevated PI3P may 
accelerate the PI3P-dependent step of Mup1 degradation, but this acceleration is not 
observed in the overall rate of the pathway because a different step, perhaps the 
ubiquitination or endocytosis of Mup1, is rate limiting. 
 
We also observed that increased PI3P production inhibits late steps in autophagy. We 
speculate that late in autophagy, excess PI3P results in the aberrant accumulation of 
PI3P-binding proteins on the surface of autophagosomes that would normally be 
released. The accumulation of these proteins crowds out other critical proteins that 
need to be recruited for the fusion of autophagosomes with the vacuole. Another 
possibility is that excess PI3P can lead to the expansion of membrane subdomains and 
dilute PI3P effectors, rendering them less functional. Support for this model comes from 
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a previous report that ymr1Dsjl3D cells, which accumulate approximately 2.5 times the 
PI3P present in wild-type cells with minimal changes to other phosphoinositides, have 
defects in retromer and ESCRT function (Parrish et al., 2004). While interpretation of 
these results is complicated by the fact that Sjl3 is reported to act on a number of 
phosphoinositide species (Guo et al., 1999; Hughes et al., 2000; Foti et al., 2001), 
excess PI3P is mislocalized in ymr1Dsjl3D cells, leading to mislocalization of PI3P-
binding proteins in the retromer and ESCRT pathways (Parrish et al., 2004). The 
differences between these previously reported results and the results reported here 
raise the possibility that the downstream effects of elevating PI3P may depend on the 
magnitude of the increase in PI3P levels or may be indicative of the differences in 
inhibiting the turnover of a PPI lipid versus accelerating its production. 
 
Previous reports of the downstream effects of elevating PPI lipid levels are limited. 
Beyond the results reported here, hyperactive mutations in Fab1 were generated in our 
lab (Duex et al., 2006b; Lang et al., 2017) as a means to determine mechanisms of 
Fab1 activation. However, the impact of these changes on downstream pathways has 
not yet been pursued. To our knowledge, the only other hyperactive mutations in PPI 
kinases that have been identified are in the mammalian PI(4,5)P2 3-kinases, including 
p110α (PIK3CA) (Rodriguez-Viciana et al., 1996; Samuels et al., 2004; Ikenoue et al., 
2005). In this context, most hyperactive mutations in p110α were identified in patient 
samples as mutations that occurred frequently in cancer (Samuels et al., 2004). 
PI(4,5)P2 3-kinase activity is required for the heregulin-induced phosphorylation of 
BRCA1 and hyperactive p110α is sufficient to induced a downstream increase in the 
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phosphorylation of BRCA1 (Altiok et al., 1999). Hyperactive p110α also induces 
downstream phosphorylation of p70 S6 kinase and 4E-binding protein 1 (Ikenoue et al., 
2005; Kang et al., 2005). Furthermore, PI(4,5)P2 3-kinase activity is required for the 
phosphorylation of AKT and for the downstream proliferation of human thyrocytes that is 
induced by oncogenic mutant RAS (Gire et al., 2000). While hyperactive p110α is 
sufficient to induce phosphorylation of AKT, it does not lead to downstream cell 
proliferation unless combined with activation of MAPK (Gire et al., 2000). Like PI(4,5)P2 
3-kinase activity, MAPK activation is necessary, but not sufficient for the proliferative 
response to mutant RAS (Gire et al., 1999), demonstrating that both signals are needed 
for cell proliferation and that hyperactive p110α does not always increase the rate of a 
complex pathway. However, other activating mutations in p110α are reported to have 
the ability to induce oncogenic transformation of NIH 3T3, mammary epithelial cells, and 
chicken embryo fibroblasts (Ikenoue et al., 2005; Isakoff et al., 2005; Kang et al., 2005), 
suggesting that different hyperactive p110α mutants may have differing effects on cell 
proliferation. Since most previous studies report that hyperactive PPI kinases 
upregulate downstream processes, our findings demonstrate that the effects of 
elevating PPI lipid levels are more complicated than previously appreciated and merit 




Figure 2.1. Generation of hyperactive Vps34 mutants. (A) Schematic indicating 
several PI3P-dependent intracellular trafficking pathways in yeast. PI3P serves as the 
substrate for PI(3,5)P2. PI3P is also required for Snx4-dependent retrograde transport 
from the vacuole and retromer-dependent retrograde transport from endosomes. 
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ESCRT function at late endosomes and the vacuole is also dependent on PI3P. 
Furthermore, PI3P is required for phagophore formation during the initiation of 
autophagy, and PI3P is then removed prior to the disassembly of some autophagy 
proteins from the surface of mature autophagosomes. In addition, fusion of 
autophagosomes and other vesicles with the vacuole, as well as homotypic vacuole 
fusion (not shown), are PI3P-dependent pathways. (B) Vps34 is proposed to be 
regulated in part via changes in contact of the Vps34 HELCAT domain with Vps15. In 
the inactive conformation, the Vps34 HELCAT domain contacts the Vps15 scaffold. 
During activation, the Vps34 HELCAT domain is proposed to alter the contact with 
Vps15 and allow Vps34 to access its PI substrate (Stjepanovic et al., 2017). (C) Crystal 
structure of the helical (light blue) and kinase (dark blue) domains of Vps34 and its 
contact with the pseudo-kinase domain of Vps15 (yellow) (Rostislavleva et al., 2015). 
The three amino acid changes that comprise the Vps34-EDC hyperactive mutant are 
indicated (red). Two of these mutations, R283E and A287D, are on an alpha-helix N-
terminal to the helical domain of Vps34 (neutral blue) and may hinder Vps34 HELCAT 
interaction with Vps15 and favor the active Vps34 conformation. The Y501C mutation is 
in the helical domain of Vps34 and faces the alpha-C helix (gray) of the kinase domain, 
nearby the activation (cyan) and catalytic (orange) loops of Vps34. (D-F) The Vps34 
mutants R283E A287D and Y501C elevate PI3P levels. PI(3,5)P2 levels are also 
elevated during hyperosmotic shock. Combining the mutants to Vps34-EDC further 
elevated PI3P levels and PI(3,5)P2 levels. vps34D cells were transformed with a wild-
type or mutant pRS416-Vps34 plasmid. PPI lipid levels were measured by metabolically 
labeling cells with myo-3H-inositol for 16 h. Prior to harvest, indicated cultures were 
exposed to 10 min of hyperosmotic shock. PPI lipid head groups were separated by 
anion exchange and HPLC. n=3. Error bars indicate standard deviation. Unpaired t-test. 




Figure 2.2. Generation of hyperactive Vps34 mutants based on a high-resolution 
structure of the Vps34-Vps15-Vps30-Vps38 complex. (A and B) Overexpression of 
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GFP-Vps34 and Vps15-13xMyc results in a modest 13% increase in PI3P levels. Wild-
type yeast cells were transformed with pRS426-GFP-Vps34, pRS425-Vps15-13xMyc, or 
both plasmids together. PPI lipid levels were measured. In parallel, GFP-Vps34 and 
Vps15-13xMyc protein levels were analyzed via western blot to measure 
overexpression. Vps15-13xMyc was detected using anti-Myc antibody. GFP-Vps34 was 
detected with anti-GFP antibody. Pgk1 was used as a loading control. Representative of 
n=3. PPI lipid levels were measured by metabolically labeling cells with myo-3H-inositol 
for 16 h, harvesting cells, and separating PPI lipid head groups by anion exchange and 
HPLC. n=3. Error bars indicate standard deviation. Unpaired t-test. ns=p>.05, *=p<.05. 
(C) Based on the crystal structure of the PI 3-kinase complex and the hypothesis that 
altering the contact between Vps34 HELCAT (helical in light blue kinase in dark blue) 
and Vps15 (yellow) would activate Vps34, we tested eight point mutants (red) in Vps34 
for elevated PI3P levels (Rostislavleva et al., 2015; Stjepanovic et al., 2017). D275K, 
R283E, A287D, and N292D are on an alpha-helix N-terminal to the helical domain of 
Vps34 (neutral blue), E323D and H322A are in the helical domain, F761Y is in the 
activation loop (cyan), and I863D is in the kinase domain. (D and E) Of the mutants 
predicted to disrupt the interaction between Vps34 HELCAT and Vps15, PI3P levels are 
most elevated by R283E and A287D (D). Combination of R283E with A287D further 
elevated PI3P levels (E). However, combining R283E A287D with additional mutations 
did not further elevated PI3P levels (E). vps34D cells were transformed with a wild-type 
or mutant pRS416-Vps34 plasmid. PPI lipid levels were measured by metabolically 
labeling cells with myo-3H-inositol for 16 h, harvesting cells, and separating PPI lipid 
head groups by anion exchange and HPLC. n=5 for WT, n=2 for R283E and A287D, 
n=3 for R283E A287D, n=1 for the rest. WT, R283E, and A287D data points are the 





Figure 2.3. Generation of hyperactive Vps34 mutants via a mutant screen. (A) A 
screen for hyperactive mutations in Vps34 was designed to identify mutants that 
rescued growth of a hypomorphic Vps34 allele, Vps34-K759D, a mutation in the 
activation loop of Vps34 that lowers PI3P levels to 22% of wild-type. vps34D cells were 
transformed with pRS416-Vps34 or pRS416-Vps34-K759D plasmids. PPI lipid levels 
were measured by metabolically labeling cells with myo-3H-inositol for 16 h, harvesting 
cells, and separating PPI lipid head groups by anion exchange and HPLC. n=1. The C-
terminal half of Vps34 was PCR amplified using mutagenic Taq DNA polymerase and a 
Vps34 plasmid was cut with restriction enzyme, XhoI, to remove the region of Vps34 
that was mutated. The plasmid backbone and mutated PCR fragment were co-
transformed into vps34D cells. Two days following co-transformation, colonies were 
replica plated to plates containing 10 nM rapamycin and grown at 33°C. Mutant Vps34 
plasmids were isolated from colonies that rescued growth on rapamycin at 33°C and 
retransformed into vps34D cells to confirm rescued growth on rapamycin at 33°C. 
Sanger sequencing was used to identify the mutations present in isolated plasmids. 22 
independent mutants revealed nine unique point mutations. Of those nine mutations, 
changes at five of them were found to elevate PI3P levels. (B) Crystal structure of the 
helical (light blue) and kinase (dark blue) domains of Vps34, indicating five residues 
identified in the hyperactive Vps34 mutant screen (red). M642V and D628V are at 
opposite ends of the alpha-C helix (gray) of the kinase domain, nearby the activation 
(cyan) and catalytic (orange) loops of Vps34. Y501C, E505G, and S506P face the 
alpha-C helix on the same side of an alpha helix in the helical domain of Vps34 (light 
pink). (C) Of the mutants identified in the Vps34 hyperactive mutant screen, PI3P levels 
are most elevated by Y501C. vps34D cells were transformed with a wild-type or mutant 
pRS416-Vps34 plasmid. PPI lipid levels were measured by metabolically labeling cells 
with myo-3H-inositol for 16 h, harvesting cells, and separating PPI lipid head groups by 
anion exchange and HPLC. n=4 for WT, n=2 for the rest. Error bars indicate standard 
deviation. (D) The Vps34 mutants R283E A287D and Y501C elevate PI3P levels during 
hyperosmotic shock. Combining the mutants to generate Vps34-EDC further elevated 
PI3P during hyperosmotic shock. vps34D cells were transformed with a wild-type or 
mutant pRS416-Vps34 plasmid. PPI lipid levels were measured by metabolically 
labeling cells with myo-3H-inositol for 16 h. Prior to harvest, indicated cultures were 
exposed to 10 min of hyperosmotic shock. PPI lipid head groups were separated by 
anion exchange and HPLC. Data are from the same samples as Figure 2.1D-F. n=3. 





Figure 2.4. Hyperactive Vps34-EDC does not affect the protein levels or 
localization of Vps34. (A and B) Hyperactive Vps34-EDC does not change 5xHA-
Vps34 protein levels. vps34D cells were transformed with pRS416-5xHA-Vps34 or 
pRS416-5xHA-Vps34-EDC. 5xHA-Vps34 protein levels were analyzed via western blot 
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using anti-HA antibody. 5xHA-Vps34 levels were normalized to Pgk1. Levels were then 
normalized to wild-type. Representative of n=3. Error bars indicate standard deviation. 
Unpaired t-test. ns=p>.05. (C and D) Hyperactive Vps34-EDC does not change the 
intensity of punctate and vacuolar Envy-Vps34 localized to the vacuole. vps34D cells 
were transformed with pRS416-Envy-Vps34 or pRS416-Envy-Vps34-EDC. After 
labeling with FM 4-64, cells were chased at 24°C for 3 h before imaging. DIC, 
differential interference contrast. Scale bar = 5 µm. The Envy-Vps34 signal that 
overlaps FM 4-64 was divided by the number of cells quantified. Quantification of at 
least 100 cells per n, n=3. The average of the wild-type samples was normalized to 1. 





Figure 2.5. Hyperactive Vps34-EDC does not affect the localization of some 
members of the PI(3,5)P2 kinase complex. (A and B) Hyperactive Vps34-EDC does 
not change the localization of Fab1-Envy to the vacuole. vps34D cells were transformed 
with pRS416-Fab1-Envy and pRS413-Vps34 or pRS413-Vps34-EDC. After labeling with 
FM 4-64, cells were chased at 24°C for 3 h before imaging. DIC, differential interference 
contrast. Scale bar = 5 µm. The Fab1-Envy signal that overlaps FM 4-64 was divided by 
the number of cells quantified. Quantification of at least 100 cells per n, n=3. The 
average of the wild-type samples was normalized to 1. Error bars indicate standard 
deviation. Unpaired t-test. ns=p>.05. (C and D) Hyperactive Vps34-EDC does not 
change the localization of Fig4-Envy to the vacuole. vps34D cells were transformed with 
pRS413-Fig4-Envy and pRS416-Vps34 or pRS416-Vps34-EDC. After labeling with FM 
4-64, cells were chased at 24°C for 3 h before imaging. DIC, differential interference 
contrast. Scale bar = 5 µm. The Fig4-Envy signal that overlaps FM 4-64 was divided by 
the number of cells quantified. Quantification of at least 100 cells per n, n=3. The 
average of the wild-type samples was normalized to 1. Error bars indicate standard 
deviation. Unpaired t-test. ns=p>.05. (E) Hyperactive Vps34-EDC does not affect the 
growth of yeast cells following hyperosmotic shock. vps34D cells were transformed with 
pRS416-Vps34 or pRS416-Vps34-EDC. Cells were grown to mid-log phase in SC 
media and then diluted to equal concentrations. An equal volume of SC media or SC 
media with 1.8 M NaCl was added to the culture to begin the time-course. ODs were 
measured immediately following the addition of SC media or SC media with 1.8 M NaCl 
and then every 4 h for 24 h. The time zero OD measurement for each sample was 
normalized to 1. A natural logarithmic transformation was applied to the normalized ODs 
so that exponential growth is represented linearly. n=4. Error bars indicate standard 




Figure 2.6. Hyperactive Vps34 increases retrograde transport of Atg27. (A-C) 
Hyperactive Vps34-EDC results in fewer cells that contain Atg27-2xGFP on the vacuole 
(FM 4-64, magenta) (B) and in less total Atg27-2xGFP colocalization with FM 4-64 (C). 
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Deletion of SNX4 results in the retention of Atg27-2xGFP on the vacuole. vps34D or 
vps34Dsnx4D cells with Atg27-2xGFP integrated at the endogenous locus were 
transformed with pRS416-Vps34 or pRS416-Vps34-EDC. After labeling with FM 4-64, 
cells were chased at 24°C for 3 h before imaging. DIC, differential interference contrast. 
Scale bar = 5 µm. Cells were scored as either having Atg27-2xGFP visible on the 
vacuole (colocalization with FM 4-64) or present only in puncta. The scorer was blinded 
to the genotype of the cells being quantified (B). To measure Atg27-2xGFP localization 
on a population basis, the Atg27-2xGFP signal that overlaps FM 4-64 was divided by 
total Atg27-2xGFP signal (C). Quantification of at least 40 cells per n, n=4. Error bars 
indicate standard deviation. Unpaired t-test. ns=p>.05, *=p<.05, **=p<.01, ***=p<.001, 
****=p<.0001. (D and E) Atg27-2xGFP partially colocalizes with the trans-Golgi (Sec7-
mCherry). This colocalization increases in the presence of hyperactive Vps34-EDC. 
vps34D cells with Atg27-2xGFP and Sec7-mCherry integrated at the endogenous loci 
were transformed with pRS416-Vps34 or pRS416-Vps34-EDC. DIC, differential 
interference contrast. Scale bar = 5 µm. Examples of Atg27-2xGFP puncta that 
colocalize with Sec7-mCherry are indicated by yellow arrows. The Atg27-2xGFP signal 
that overlaps Sec7-mCherry was divided by total Atg27-2xGFP signal. Quantification of 
at least 40 cells per n, n=4. Error bars indicate standard deviation. Unpaired t-test. 
*=p<.05. (F and G) Atg27-2xGFP partially colocalizes with endosomes (Vps8-mCherry). 
This colocalization is not statistically different for hyperactive Vps34-EDC compared to 
wild-type. vps34D cells with Atg27-2xGFP and Vps8-mCherry integrated at the 
endogenous loci were transformed with pRS416-Vps34 or pRS416-Vps34-EDC. DIC, 
differential interference contrast. Scale bar = 5 µm. Examples of Atg27-2xGFP puncta 
that colocalize with Vps8-mCherry are indicated by yellow arrows. The Atg27-2xGFP 
signal that overlaps Vps8-mCherry was divided by total Atg27-2xGFP signal. 
Quantification of at least 40 cells per n, n=4. Error bars indicate standard deviation. 




Figure 2.7. Hyperactive Vps34 increases retrograde transport of Atg27. (A) 
Hyperactive Vps34-EDC does not change the localization of the GFP-Yck3 kinase, an 
AP-3 client protein localized to the vacuole membrane. vps34D cells were co-
transformed with pRS413-Vps34 or pRS413-Vps34-EDC and pRS416-GFP-Yck3. After 
labeling with FM 4-64, cells were chased at 24°C for 3 h before imaging. DIC, 
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differential interference contrast. Scale bar = 5 µm. At least 40 cells per n, n=3. (B and 
C) Atg27-2xGFP partially colocalizes with the trans-Golgi (Sec7-mCherry). This 
colocalization increases in the presence of hyperactive Vps34-EDC. In the absence of 
VPS35, Atg27-2xGFP colocalization with the trans-Golgi is unchanged between wild-
type and Vps34-EDC. vps34D or vps34D vps35D cells with Atg27-2xGFP and Sec7-
mCherry integrated at the endogenous loci were transformed with pRS416-Vps34 or 
pRS416-Vps34-EDC. DIC, differential interference contrast. Scale bar = 5 µm. 
Examples of Atg27-2xGFP puncta that colocalize with Sec7-mCherry are indicated by 
yellow arrows. The Atg27-2xGFP signal that overlaps Sec7-mCherry was divided by 
total Atg27-2xGFP signal. Quantification of at least 40 cells per n, n=4. Error bars 
indicate standard deviation. Unpaired t-test. ns=p>.05, *=p<.05, **=p<.01, ***=p<.001. 
(D) Deletion of VPS35 does not change the localization of the GFP-Yck3 kinase, an AP-
3 client protein localized to the vacuole membrane. Wild-type or vps35∆ cells were 
transformed with pRS416-GFP-Yck3. After labeling with FM 4-64, cells were chased at 
24°C for 3 h before imaging. DIC, differential interference contrast. Scale bar = 5 µm. At 




Figure 2.8. Hyperactive Vps34 does not affect ESCRT-dependent degradation of 
amino acid transporters Ypq1 or Mup1. (A and B) ESCRT-dependent internalization 
of Ypq1-GFP following the withdrawal of lysine is not statistically significantly different 
for hyperactive Vps34-EDC compared to wild-type. vps34D cells were transformed with 
pRS416-Vps34 or pRS416-Vps34-EDC and pRS414-Ypq1-GFP. To induce Ypq1-GFP 
internalization, cells were transferred to media lacking lysine. Samples were collected at 
0 and 5 h following lysine withdrawal. Ypq1-GFP protein levels were analyzed via 
western blot using anti-GFP antibody and were normalized to Vph1. Levels were then 
normalized to wild-type at the zero time-point. Representative of n=4. Error bars indicate 
standard deviation. Unpaired t-test. ns=p>.05. (C and D) ESCRT-dependent 
internalization of Mup1-GFP following the addition of methionine is not statistically 
significantly different for hyperactive Vps34-EDC compared to wild-type. vps34D cells 
were transformed with pRS416-Vps34 or pRS416-Vps34-EDC and pRS414-Mup1-GFP. 
Cells were grown in media lacking methionine. To induce Mup1-GFP internalization, 
cells were transferred to media containing methionine. Samples were collected at the 
indicated time points following methionine addition. Mup1-GFP protein levels were 
analyzed via western blot using anti-GFP antibody and normalized to Pgk1. Levels were 
then normalized to wild-type at the zero time-point. Representative of n=4. Error bars 
indicate standard deviation. The degradation rate of Mup1-GFP was determined using a 
linear mixed effects model. The logarithmic transformation of Mup1-GFP levels was 
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modelled as a linear function of time and allowed to vary by genotype. Replicate-
specific intercepts were included to account for residual correlation between protein 
levels within the same replicate. The difference in degradation rates between genotypes 
was not statistically significant (a 95% confidence interval of the genotype by time 
interaction contained 0). The equation generated by the linear mixed effects model is 
plotted (D). The half-life of Mup1-GFP following re-addition of methionine was 
calculated to be 33.7 min (SEM 2.39 min) with wild-type Vps34, and 30.8 min (SEM 




Figure 2.9. Hyperactive Vps34 inhibits a late step in autophagy. (A and B) 
Comparison of Atg8–PE protein levels in the absence and presence of PMSF, a 
protease inhibitor, suggests that Vps34-EDC inhibits a late step in autophagy, but does 
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not change the rate of autophagy induction. During autophagy, the levels of Atg8–PE 
are determined by both covalent attachment of phosphatidylethanolamine (PE) to Atg8 
and by degradation of Atg8–PE once autophagosomes fuse with the vacuole. When 
degradation of Atg8–PE is inhibited by the serine protease inhibitor, PMSF, there was 
no difference in Atg8–PE levels in Vps34-WT compared to Vps34-EDC, suggesting that 
autophagy induction is unchanged by Vps34-EDC. However, in the absence of PMSF, 
Atg8–PE protein levels are elevated by hyperactive Vps34-EDC following 1 h of 
nitrogen starvation, suggesting that Vps34-EDC inhibits a late step in autophagy. 
vps34D cells were transformed with pRS416-Vps34 or pRS416-Vps34-EDC. Atg8–PE 
protein levels were analyzed via western blot using anti-Atg8 antibody. Atg8–PE levels 
were normalized to Pgk1. Levels were further normalized to wild-type at 1 h of nitrogen 
starvation. Representative of n=3. Error bars indicate standard deviation. Unpaired t-
test. ns=p>.05, *=p<.05. (C and D) Following 15 and 30 min of nitrogen starvation, 
Atg8–PE protein levels are unchanged between hyperactive Vps34-EDC and wild-type 
when degradation of Atg8–PE is inhibited by the protease inhibitor, PMSF. This result 
suggests that Vps34-EDC does not affect autophagy induction. vps34D cells were 
transformed with pRS416-Vps34 or pRS416-Vps34-EDC. Atg8–PE protein levels were 
analyzed via western blot using anti-Atg8 antibody. Atg8–PE levels were normalized to 
Pgk1. Levels were further normalized to wild-type at 15 and 30 min following nitrogen 
starvation. Representative of n=4. Error bars indicate standard deviation. Unpaired t-
test. ns=p>.05. (E and F) Hyperactive Vps34-EDC results in an increase in the lifetime 
of GFP-Atg8 puncta in cells. vps34D cells were co-transformed with pRS414-GFP-Atg8 
and pRS416-Vps34 or pRS416-Vps34-EDC. Cells were imaged every minute for 26 min 
following 30 min of nitrogen starvation. 20 z-slices that were 0.2 µm apart were acquired 
at each time point. Single z-slice. DIC, differential interference contrast. Scale bar = 3.5 
µm. GFP-Atg8 puncta were tracked over time with the lifetime of each puncta calculated 
as the time between the first and last frames the puncta were visible. Only GFP-Atg8 
puncta that could be followed unambiguously over their lifetime were analyzed. For wild-






Figure 2.10. Hyperactive Vps34 inhibits a late step in autophagy. (A) mRNA levels 
of ATG1, ATG7, and ATG9 are unchanged between Vps34-EDC and wild-type, 
suggesting that Vps34-EDC does not affect the transcription of select autophagy genes. 
vps34D cells were transformed with pRS416-Vps34 or pRS416-Vps34-EDC. ATG1, 
ATG7, and ATG9 mRNA transcript levels were measured by qRT-PCR in nitrogen rich 
conditions and following 30 min of nitrogen starvation. mRNA levels were normalized to 
wild-type in nitrogen rich conditions. n=3. Error bars indicate standard deviation. 
Unpaired t-test. ns=p>.05. (B and C) Hyperactive Vps34-EDC results in an increase in 
the number of GFP-Atg8 puncta in cells following 30 min of nitrogen starvation. vps34D 
cells were co-transformed with pRS414-GFP-Atg8 and pRS416-Vps34 or pRS416-
Vps34-EDC. After labeling with FM 4-64, cells were chased at 24°C for 3 h before 9 z-
slices that were 0.2 µm apart were imaged. Maximum intensity projection. DIC, 
differential interference contrast. Scale bar = 5 µm. GFP-Atg8 puncta were counted by a 
scorer who was blinded to the genotype of the cells being quantified. Quantification of at 
least 100 cells per n, n=3. Error bars indicate standard deviation. Two-way ANOVA and 
Dunnett’s post-hoc test. ns=p>.05, *=p<.05, **=p<.01. (D) Hyperactive Vps34-EDC does 
not cause an increase in the number of GFP-Atg8 puncta in vam3D cells after 1 h of 
nitrogen starvation. This experiment is an alternative quantification of the experiment 
performed in Figure 2.11D and E. vps34D vam3D cells with Atg18-RFP integrated at the 
endogenous locus were transformed with pRS413-GFP-Atg8 and pRS416-Vps34 or 
pRS416-Vps34-EDC. GFP-Atg8 puncta were counted by a scorer who was blinded to 
the genotype of the cells being quantified. Cells without visible Atg18-RFP were 
excluded from quantification. Quantification of 100 cells per n, n=4. Error bars indicate 
standard deviation. Unpaired t-test. ns=p>.05. (E and F) Vps34-EDC does not change 
Atg18-GFP protein levels at basal conditions or during nitrogen starvation. vps34D cells 
were co-transformed with pRS413-Vps34 or pRS413-Vps34-EDC and pRS416-Atg18-
GFP. Atg18-GFP protein levels were analyzed via western blot using anti-GFP 
antibody. Atg18-GFP levels were normalized to Dpm1. Levels were then normalized to 
wild-type at basal conditions. Representative of n=3. Error bars indicate standard 
deviation. Unpaired t-test. ns=p>.05. (G) Hyperactive Vps34-EDC does not affect the 
survival of yeast cells during long-term nitrogen starvation. vps34D cells were 
transformed with pRS416-Vps34 or pRS416-Vps34-EDC and grown to mid-log phase in 
SC media. Equal numbers of cells were collected and rinsed twice in nitrogen-starvation 
media before resuspending in nitrogen-starvation media. Following 1 day and 14 days 
of nitrogen starvation, equal volumes of culture were serially diluted 1:5 and spotted on 
SC plates. Plates were imaged following 3 days of yeast growth. 2 representative 




Figure 2.11. Hyperactive Vps34 inhibits a late step in autophagy. (A and B) The 
Vps34-EDC mutant or deletion of YMR1 inhibits degradation of GFP-Atg8 following 
nitrogen starvation. Combining Vps34-EDC with a deletion of YMR1 further inhibits 
degradation of GFP-Atg8, indicating a block in autophagy flux. vps34D or vps34D ymr1D 
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cells were co-transformed with pRS416-Vps34 or pRS416-Vps34-EDC and copper 
inducible pRS414-pCup1-GFP-Atg8. No exogenous copper was added during this 
experiment. GFP-Atg8 and GFP protein levels were analyzed via western blot using 
anti-GFP antibody. Free GFP levels were divided by the sum of GFP-Atg8 and free 
GFP and expressed as a percent. Representative of n=3. Error bars indicate standard 
deviation. Unpaired t-test. ns=p>.05, *=p<.05, **=p<.01, ***=p<.001, ****=p<.0001. (C) 
The Vps34-EDC mutant and deletion of the yeast myotubularin gene YMR1 elevated 
PI3P levels. Combining Vps34-EDC with deletion of YMR1 further elevated PI3P levels. 
vps34D or vps34D ymr1D cells were transformed with pRS416-Vps34 or pRS416-
Vps34-EDC. PPI lipid levels were measured by metabolically labeling cells with myo-3H-
inositol for 16 h, harvesting cells, and separating PPI lipid head groups by anion 
exchange and HPLC. n=3. Error bars indicate standard deviation. Unpaired t-test. 
*=p<.05, **=p<.01. (D and E) Hyperactive Vps34-EDC leads to a defect in disassembly 
of the autophagy machinery from the surface of mature autophagosomes as well as a 
defect in fusion of autophagosomes with the vacuole. In the presence of Vam3, Vps34-
EDC caused a small but statistically significant decrease in the percentage of GFP-Atg8 
puncta that colocalize with Atg18-RFP after 1 h of nitrogen starvation. This suggests 
that Vps34-EDC leads to a minor defect in fusion of autophagosomes with the vacuole. 
However, in vam3D cells where fusion of autophagosomes with the vacuole is 
completely blocked, hyperactive Vps34-EDC leads to a small but statistically significant 
increase in the percentage of GFP-Atg8 puncta that colocalize with Atg18-RFP after 1 h 
of nitrogen starvation. This result suggests that Vps34-EDC also leads to a minor defect 
in the dissociation of key autophagy machinery from mature autophagosomes. vps34D 
or vps34D vam3D cells with Atg18-RFP integrated at the endogenous locus were 
transformed with pRS413-GFP-Atg8 and pRS416-Vps34 or pRS416-Vps34-EDC. Cells 
were imaged after 1 h of nitrogen starvation. DIC, differential interference contrast. 
Scale bar = 5 µm. Individual GFP-Atg8 puncta were scored on whether or not they 
colocalized with Atg18-RFP puncta. The scorer was blinded to the genotype of the cells 
being quantified. Cells without visible Atg18-RFP were excluded from quantification. 
Examples of GFP-Atg8 puncta that colocalize with Atg18-RFP are indicated by yellow 
arrows. Examples of GFP-Atg8 puncta that do not colocalize with Atg18-RFP are 
indicated by white arrows. Quantification of 100 cells per n, n=4. Error bars indicate 




Figure 2.12. Hyperactive Vps34-EDC may lead to a modest decrease in homotypic 
vacuole fusion. (A-C) Hyperactive Vps34-EDC results in a 12% increase in the 
average number of vacuole lobes in a cell (B), which occurs primarily due to a decrease 
in the number of cells with 1 vacuole lobe (C). vps34D cells were transformed with 
pRS416-Vps34 or pRS416-Vps34-EDC. After labeling with FM 4-64, cells were chased 
at 24°C for 3 h before imaging. DIC, differential interference contrast. Scale bar = 5 µm. 
The number of vacuole lobes was counted by a scorer who was blinded to the genotype 
of the cells being quantified. Quantification of at least 100 cells per n, n=4. Error bars 
indicate standard deviation. Unpaired t-test (B). Two-way ANOVA and Dunnett’s post-




Altiok, S., Batt, D., Altiok, N., Papautsky, A., Downward, J., Roberts, T.M., and 
Avraham, H. (1999). Heregulin induces phosphorylation of BRCA1 through 
phosphatidylinositol 3-Kinase/AKT in breast cancer cells. J Biol Chem 274, 32274-
32278. 
Balla, T. (2013). Phosphoinositides: tiny lipids with giant impact on cell regulation. 
Physiol Rev 93, 1019-1137. 
Barbet, N.C., Schneider, U., Helliwell, S.B., Stansfield, I., Tuite, M.F., and Hall, M.N. 
(1996). TOR controls translation initiation and early G1 progression in yeast. Mol Biol 
Cell 7, 25-42. 
Bas, L., Papinski, D., Licheva, M., Torggler, R., Rohringer, S., Schuschnig, M., and 
Kraft, C. (2018). Reconstitution reveals Ykt6 as the autophagosomal SNARE in 
autophagosome-vacuole fusion. J Cell Biol. 
Botelho, R.J., Efe, J.A., Teis, D., and Emr, S.D. (2008). Assembly of a Fab1 
phosphoinositide kinase signaling complex requires the Fig4 phosphoinositide 
phosphatase. Mol Biol Cell 19, 4273-4286. 
Cebollero, E., van der Vaart, A., Zhao, M., Rieter, E., Klionsky, D.J., Helms, J.B., and 
Reggiori, F. (2012). Phosphatidylinositol-3-phosphate clearance plays a key role in 
autophagosome completion. Curr Biol 22, 1545-1553. 
Delorme-Axford, E., and Klionsky, D.J. (2018). Transcriptional and post-transcriptional 
regulation of autophagy in the yeast Saccharomyces cerevisiae. J Biol Chem 293, 
5396-5403. 
Duex, J.E., Nau, J.J., Kauffman, E.J., and Weisman, L.S. (2006a). Phosphoinositide 5-
phosphatase Fig 4p is required for both acute rise and subsequent fall in stress-induced 
phosphatidylinositol 3,5-bisphosphate levels. Eukaryot Cell 5, 723-731. 
Duex, J.E., Tang, F., and Weisman, L.S. (2006b). The Vac14p-Fig4p complex acts 
independently of Vac7p and couples PI3,5P2 synthesis and turnover. J Cell Biol 172, 
693-704. 
Foti, M., Audhya, A., and Emr, S.D. (2001). Sac1 lipid phosphatase and Stt4 
phosphatidylinositol 4-kinase regulate a pool of phosphatidylinositol 4-phosphate that 
functions in the control of the actin cytoskeleton and vacuole morphology. Mol Biol Cell 
12, 2396-2411. 
Gary, J.D., Sato, T.K., Stefan, C.J., Bonangelino, C.J., Weisman, L.S., and Emr, S.D. 
(2002). Regulation of Fab1 phosphatidylinositol 3-phosphate 5-kinase pathway by Vac7 
protein and Fig4, a polyphosphoinositide phosphatase family member. Mol Biol Cell 13, 
1238-1251. 
 74 
Gary, J.D., Wurmser, A.E., Bonangelino, C.J., Weisman, L.S., and Emr, S.D. (1998). 
Fab1p is essential for PtdIns(3)P 5-kinase activity and the maintenance of vacuolar size 
and membrane homeostasis. J Cell Biol 143, 65-79. 
Gire, V., Marshall, C., and Wynford-Thomas, D. (2000). PI-3-kinase is an essential anti-
apoptotic effector in the proliferative response of primary human epithelial cells to 
mutant RAS. Oncogene 19, 2269-2276. 
Gire, V., Marshall, C.J., and Wynford-Thomas, D. (1999). Activation of mitogen-
activated protein kinase is necessary but not sufficient for proliferation of human thyroid 
epithelial cells induced by mutant Ras. Oncogene 18, 4819-4832. 
Guo, S., Stolz, L.E., Lemrow, S.M., and York, J.D. (1999). SAC1-like domains of yeast 
SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide 
phosphatases. J Biol Chem 274, 12990-12995. 
Hughes, W.E., Woscholski, R., Cooke, F.T., Patrick, R.S., Dove, S.K., McDonald, N.Q., 
and Parker, P.J. (2000). SAC1 encodes a regulated lipid phosphoinositide phosphatase, 
defects in which can be suppressed by the homologous Inp52p and Inp53p 
phosphatases. J Biol Chem 275, 801-808. 
Ichimura, Y., Kirisako, T., Takao, T., Satomi, Y., Shimonishi, Y., Ishihara, N., 
Mizushima, N., Tanida, I., Kominami, E., Ohsumi, M., et al. (2000). A ubiquitin-like 
system mediates protein lipidation. Nature 408, 488-492. 
Ikenoue, T., Kanai, F., Hikiba, Y., Obata, T., Tanaka, Y., Imamura, J., Ohta, M., Jazag, 
A., Guleng, B., Tateishi, K., et al. (2005). Functional analysis of PIK3CA gene mutations 
in human colorectal cancer. Cancer Res 65, 4562-4567. 
Isakoff, S.J., Engelman, J.A., Irie, H.Y., Luo, J., Brachmann, S.M., Pearline, R.V., 
Cantley, L.C., and Brugge, J.S. (2005). Breast cancer-associated PIK3CA mutations are 
oncogenic in mammary epithelial cells. Cancer Res 65, 10992-11000. 
Kang, S., Bader, A.G., and Vogt, P.K. (2005). Phosphatidylinositol 3-kinase mutations 
identified in human cancer are oncogenic. Proc Natl Acad Sci U S A 102, 802-807. 
Kihara, A., Noda, T., Ishihara, N., and Ohsumi, Y. (2001). Two distinct Vps34 
phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y 
sorting in Saccharomyces cerevisiae. J Cell Biol 152, 519-530. 
Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., Abeliovich, H., Acevedo 
Arozena, A., Adachi, H., Adams, C.M., Adams, P.D., Adeli, K., et al. (2016). Guidelines 
for the use and interpretation of assays for monitoring autophagy (3rd edition). 
Autophagy 12, 1-222. 
Lang, M.J., Strunk, B.S., Azad, N., Petersen, J.L., and Weisman, L.S. (2017). An 
intramolecular interaction within the lipid kinase Fab1 regulates cellular 
phosphatidylinositol 3,5-bisphosphate lipid levels. Mol Biol Cell. 
 75 
Li, M., Rong, Y., Chuang, Y.S., Peng, D., and Emr, S.D. (2015). Ubiquitin-dependent 
lysosomal membrane protein sorting and degradation. Mol Cell 57, 467-478. 
Ma, M., Burd, C.G., and Chi, R.J. (2017). Distinct complexes of yeast Snx4 family SNX-
BARs mediate retrograde trafficking of Snc1 and Atg27. Traffic 18, 134-144. 
Menant, A., Barbey, R., and Thomas, D. (2006). Substrate-mediated remodeling of 
methionine transport by multiple ubiquitin-dependent mechanisms in yeast cells. EMBO 
J 25, 4436-4447. 
Parrish, W.R., Stefan, C.J., and Emr, S.D. (2004). Essential role for the myotubularin-
related phosphatase Ymr1p and the synaptojanin-like phosphatases Sjl2p and Sjl3p in 
regulation of phosphatidylinositol 3-phosphate in yeast. Mol Biol Cell 15, 3567-3579. 
Rodriguez-Viciana, P., Warne, P.H., Vanhaesebroeck, B., Waterfield, M.D., and 
Downward, J. (1996). Activation of phosphoinositide 3-kinase by interaction with Ras 
and by point mutation. EMBO J 15, 2442-2451. 
Rostislavleva, K., Soler, N., Ohashi, Y., Zhang, L., Pardon, E., Burke, J.E., Masson, 
G.R., Johnson, C., Steyaert, J., Ktistakis, N.T., et al. (2015). Structure and flexibility of 
the endosomal Vps34 complex reveals the basis of its function on membranes. Science 
350, aac7365. 
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, 
A., Powell, S.M., Riggins, G.J., et al. (2004). High frequency of mutations of the PIK3CA 
gene in human cancers. Science 304, 554. 
Segarra, V.A., Boettner, D.R., and Lemmon, S.K. (2015). Atg27 tyrosine sorting motif is 
important for its trafficking and Atg9 localization. Traffic 16, 365-378. 
Stjepanovic, G., Baskaran, S., Lin, M.G., and Hurley, J.H. (2017). Vps34 Kinase 
Domain Dynamics Regulate the Autophagic PI 3-Kinase Complex. Mol Cell 67, 528-534 
e523. 
Strunk, B.S., Steinfeld, N., Lee, S., Jin, N., Munoz-Rivera, C., Meeks, G., Thomas, A., 
Akemann, C., Mapp, A.K., MacGurn, J.A., et al. (2020). Roles for a lipid phosphatase in 
the activation of its opposing lipid kinase. Mol Biol Cell 31, 1835-1845. 
Sun, B., Chen, L., Cao, W., Roth, A.F., and Davis, N.G. (2004). The yeast casein kinase 
Yck3p is palmitoylated, then sorted to the vacuolar membrane with AP-3-dependent 
recognition of a YXXPhi adaptin sorting signal. Mol Biol Cell 15, 1397-1406. 
Suzuki, S.W., and Emr, S.D. (2018). Membrane protein recycling from the 
vacuole/lysosome membrane. J Cell Biol 217, 1623-1632. 
Taylor, S.S., Shaw, A.S., Kannan, N., and Kornev, A.P. (2015). Integration of signaling 
in the kinome: Architecture and regulation of the alphaC Helix. Biochim Biophys Acta 
1854, 1567-1574. 
 76 
Teis, D., Saksena, S., and Emr, S.D. (2008). Ordered assembly of the ESCRT-III 
complex on endosomes is required to sequester cargo during MVB formation. Dev Cell 
15, 578-589. 
Zhu, L., Jorgensen, J.R., Li, M., Chuang, Y.S., and Emr, S.D. (2017). ESCRTs function 
directly on the lysosome membrane to downregulate ubiquitinated lysosomal membrane 







Studies with hyperactive Vps34 revealed that elevating phosphoinositide (PPI) lipids 
selectively impact a subset of downstream processes that require a specific PPI. We 
find that hyperactive Vps34 can drive certain pathways, inhibit other pathways, and 
have no measurable effect on others. Our studies suggest that stimulus-induced 
elevation of phosphoinositides provides a way for these stimuli to selectively regulate 
downstream processes. However, there are still gaps in our understanding of the 
biological roles and regulation of PI3P. 
 
Evidence for another PI 3-kinase in yeast 
Others have suggested that Vps34 is the sole enzyme responsible for generating PI3P 
from PI in yeast because of reports that no PI3P is detected in vps34D cells (Schu et al., 
1993). In my own studies, however, when examining elution profiles of PPI lipids 
separated by anion exchange chromatography in vps34D cells, a small peak elutes at 
the same location where the PI3P peak elutes in wild-type cells (Figure 3.1). I have not 
tried to analyze this peak further. If this peak is due to PI3P, this would raise the 
possibility that an as yet unidentified PI 3-kinase generates a small pool of PI3P in 
yeast. Tor1 is a potential candidate to have a small amount of PI 3-kinase activity, as it 
 78 
contains a domain with significant sequence similarity to yeast and mammalian Vps34 
(Cafferkey et al., 1993). 
 
Gleaning mechanistic insights into the regulation of Vps34 
Previously, our lab generated hyperactive mutations in the PI3P 5-kinase, Fab1, by 
screening for mutants that rescued Fab1 function in strains where key Fab1 activators 
were knocked out (Duex et al., 2006; Lang et al., 2017). These mutants led to 
mechanistic insights into the regulation of Fab1 (Lang et al., 2017). In this study, instead 
of knocking out genes encoding Vps34 regulators, we performed a screen based on 
rescuing growth of a hypomorphic Vps34 allele that was mutated near the active site of 
the enzyme. The mutants identified in this screen were concentrated near the active site 
of the kinase and most likely help favor an active conformation of the kinase, but may 
not be regulatory sites on the native enzyme. In support of this idea, we found that while 
mutations near the active site such as Y501C and D628V rescued the growth of the 
K759D mutant on several conditions tested, the R283E A287D mutants did not (Figure 
3.2). Thus, these two different screening strategies appear to return mutations that 
provide insight into different aspects of PPI kinase function and regulation. These 
differences should guide the design of future screens for hyperactive PPI kinases. A 
screen that avoids crippling the active site of the kinase is more likely to yield 
mechanistic insights into the regulation of a PPI kinase. When regulators of PPI kinases 
are not known or when the sole goal of a hyperactive mutant is to determine 
downstream effects of elevating a PPI lipid, a screening strategy based on a 
hypomorphic PPI kinase allele is straightforward because catalytic site residues can be 
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readily identified. Going forward, to glean new mechanistic insights into the regulation of 
Vps34, it may be informative to screen for mutants that rescue Vps34 function in strains 
where key Vps34 activators are knocked out. 
 
Additional screens to identify hyperactive mutants in PI 3-kinase complex 
components 
We have begun the process of identifying screening conditions to generate hyperactive 
Vps34 mutants that can provide novel insights into the regulation of Vps34. We found 
that, unlike the Vps34-K759D mutant, all tested hyperactive Vps34 were able to rescue 
growth of vps30Δ cells grown at 33°C on plates containing 15mM ZnSO4 (Figure 3.3). 
Using these new conditions, we performed an unbiased genetic screen for hyperactive 
Vps34 mutants that rescue growth of vps30D cells (Figure 3.4). Different from the 
previous screen, we performed random PCR mutagenesis on the N-terminal rather than 
C-terminal half of Vps34 and were able to isolate 25 mutants (Figure 3.5). Of the 
mutants generated, we were encouraged that we isolated mutations at amino acid R283 
(orange), as the R283E mutant was already confirmed to be hyperactive. Additionally, 
we isolated mutations at nearby E285 and R286 (orange), suggesting that multiple 
mutations on this helix can result in hyperactive Vps34. Also encouraging was the 
isolation of two mutants on the alpha-C helix, Q633K and E644K, a region of Vps34 
where hyperactive mutants D628V and M642V were already identified. 
 
Interestingly, there were also two clusters of mutants in the helical domain of Vps34 that 
possibly represent novel regulatory sites on Vps34 (yellow and blue). However, a 
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number of these mutants included mutations to glycine and proline, amino acids with 
poor propensity to form helices and thus may be disrupting the folding of the helical 
domain rather than acting as a true regulatory site. If, however, these mutants were 
disrupting the binding of a Vps34 regulator to the helical domain, we reasoned that 
charge reversal mutations in charged residues on the surface of Vps34 in these regions 
would disrupt the binding of the Vps34 regulator, while not affecting the folding of the 
helical domain. Thus, we selected three mutations, E353K, R388E, and E417K on the 
surface of the helical domain in these clusters (Figure 3.6) and tested whether these 
mutants led to increased production of PI3P, finding that none of the three mutants 
resulted in significant increases in PI3P levels (Figure 3.7). While it is possible that 
these clusters do represent bonified regulatory sites for Vps34, this result suggests that 
the mutants identified in the screen may simply be disrupting the folding of the Vps34 
helical domain. 
 
Going forward, additional hyperactive mutant screens may be informative in 
understanding more about the regulation of the yeast PI 3-kinase complexes. It may be 
instructive to repeat the screen described above for Vps34 mutants that rescue growth 
of vps30Δ cells grown at 33°C on plates containing 15mM ZnSO4. Alternatively, it may 
be useful to identify a different growth condition for the screen or to perform the screen 
with a different PI 3-kinase complex protein knocked out. One option would be to 
perform the screen in vps38Δ cells, which maintain PI3P levels similar to vps30Δ cells 
(Burda et al., 2002). On the other hand, it may also be informative to identify conditions 
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to perform a screen in vps15D cells, which do not produce detectable levels of PI3P 
(Stack et al., 1993). 
 
It may also be informative to screen for hyperactive mutants in other members of the PI 
3-kinase complex. We designed a screen to identify hyperactive mutations in Vps15 that 
elevate PI3P levels. The screen was based on rescued growth of vps30Δ cells grown at 
33°C on plates containing 21 mM ZnSO4. However, of the plasmids isolated from the 26 
colonies that grew on 21 mM ZnSO4 at 33°C, none were able to rescue growth on 21 
mM ZnSO4 at 33°C when retransformed into vps15Δvps30Δ cells. This result suggested 
that growth was rescued in these colonies by mutations at other places in the genome 
and raises the possibility that hyperactive mutations in Vps15 are difficult to generate. In 
the future, it may still be informative to repeat this screen to try to identify hyperactive 
mutations in Vps15 or to identify mutations in the genomes of colonies that rescue 
growth, but do not contain mutations in Vps15. Furthermore, it may also be instructive to 
identify a different growth condition for a Vps15 hyperactive mutant screen or to identify 
conditions to screen for hyperactive mutations in Vps30, Vps38, or Atg14. 
 
Evidence and potential roles for a third Vps34-containing complex 
There are a number of clues in the literature that Vps34/Vps15 maintain some functions 
independent of the other subunits in complexes I and II. In addition to defects in CPY 
and API maturation and autophagy, vps15D and vps34D cells exhibit temperature 
sensitive growth at 37°C and have defects in PrA and PrB maturation that are not 
present in vps30D, vps38D, or atg14D cells (Kihara et al., 2001) (Figure 1.3). 
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Furthermore, while vps30D, vps38D, and vps30Dvps38D cells maintain about 30% of 
their normal PI3P levels (Burda et al., 2002) and atg14D cells exhibit near wild-type 
PI3P levels (Kihara et al., 2001), vps34D and vps15D cells have almost no detectable 
PI3P. These results raise two major possibilities: either Vps34 and Vps15 retain partial 
function that is independent of Vps30, Vps38, and Atg14, or Vps34 and Vps15 are 
members of an as yet unidentified third Vps34-containing complex in yeast. 
 
The fact that vps30D and vps38D cells exhibit a defect in CPY maturation, but not PrA 
and PrB maturation is intriguing because vps15D and vps34D cells exhibit defects in 
PrA and PrB maturation and PrA and B and CPY follow a similar maturation pathway 
(Kihara et al., 2001) (Figure 1.3). This difference potentially points to a role for a 
hypothesized third yeast PI 3-kinase complex. Vps10, a yeast mannose-6 phosphate 
receptor, acts as a sorting receptor for both CPY and PrA and cycles between the Golgi 
and endosomes (Westphal et al., 1996). However, in a vps10Δ mutant, while most CPY 
does not mature, ~85% of PrA still matures. In vps38D cells, Vps10 mislocalizes from 
endosomes to the vacuolar membrane (Burda et al., 2002). Retromer components Vps5 
and Vps17 also mislocalize to the cytoplasm in vps38D cells. Taken together, this result 
suggests that the retromer is required for Vps10 cycling between Golgi and endosome 
and that disrupting this cycling affects CPY maturation. Mrl1, a relatively 
uncharacterized homolog of mammalian mannose-6 phosphate receptors, was 
identified as a partially redundant PrA sorting receptor. Simultaneous mutation of Vps10 
and Mrl1 causes a much larger PrA sorting defect than mutation of Vps10 alone (Whyte 
and Munro, 2001). This result raised the possibility that Mrl1 will localize correctly in 
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vps38D and vps30D cells, but will mislocalize in a Vps34 mutant, suggesting a model in 
which Mrl1 recycles to the Golgi in a retromer-independent manner and in a manner 
that is independent of Vps30 and Vps38. However, I tested the localization of Mrl1 in PI 
3-kinase complex mutants and found that Mrl1 localized normally in wild-type and 
atg14D cells, but mislocalized to the vacuole in vps38D, vps30D, vps15D, and vps34D 
cells (Figure 3.8). This result demonstrates that instead of being complex II-
independent, Mrl1 localization depends on PI 3-kinase complex II. 
 
In addition to temperature sensitive growth at 37°C and defects in Proteinase A and B 
maturation, vps34D and vps15D cells, but not vps30D, vps38D, or atg14D cells also 
exhibit a defect in pheromone signaling (Slessareva et al., 2006) that could potentially 
be a role for a third yeast PI 3-kinase complex. Similarly, neither Vps30 or Vps38 are 
required for delivery of CPS to the vacuolar lumen (Burda et al., 2002), suggesting that 
ESCRT function may be a complex I and II-independent role for Vps34. As further 
evidence, I determined that the ESCRT and PI3P-dependent internalization of the 
vacuolar cationic amino acid transporter Ypq1 (Zhu et al., 2017) occurs in a complex I 
and II-independent manner (Figure 3.9). While Ypq1 is not internalized into the vacuole 
lumen in vps34D and vps15D cells, Ypq1 internalization is not affected in vps30D, 
vps38D, atg14D, and vps38Datg14D cells. 
 
Vps34 localization to autophagosomes is Atg14-dependent and the localization to 
puncta, which are postulated to be endosomes is Vps38-dependent. However, in 
addition to localizing to endosomes and autophagosomes, Vps34 also localizes on the 
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vacuole (Obara et al., 2006). We hypothesize that a third PI 3-kinase complex could be 
required for Vps34 localization to the vacuole and might be required for the PI3P-
dependent internalization of Ypq1, which occurs on the vacuole (Zhu et al., 2017). 
 
A method of identifying the members of a third PI 3-kinase complex 
Identifying the members of a potential third PI 3-kinase regulatory complex is likely to be 
difficult and may require both biochemical and genetic approaches. Candidates for 
members of a third PI 3-kinase regulatory complex can be identified biochemically via 
immunoprecipitation of Vps34 and/or Vps15 and mass spectrometry of their interactors. 
A similar approach was recently used to identify the novel complex I interactor, Atg38 
(Araki et al., 2013). Immunoprecipitation of Vps34 and Vps15 and mass spectrometry of 
their interactors has also been performed by other groups (Graef et al., 2013). 
Genetically, there are a number of ways one might narrow down candidates for 
members of a third PI 3-kinase regulatory complex. In my experience, vps34D and 
vps15D cells grow much slower than vps30D, vps38D, or atg14D cells. Thus, it is 
possible that a member of a third PI 3-kinase complex would exhibit a synthetic growth 
defect with Vps30. A member of a third PI 3-kinase complex would also likely be 
defective in a PI3P-dependent process that is independent of complex I and II, for 
example, a defect in pheromone signaling (Slessareva et al., 2006) and/or ESCRT 
function (Burda et al., 2002; Zhu et al., 2017). Some genetic screens have identified 
mutations that disrupt ESCRT function. These mutants include the class E Vps mutants 
(Raymond et al., 1992), which have been characterized as being defective for ESCRT 
function (Coonrod and Stevens, 2010). Additionally, a recent screen identified mutants 
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defective for PI3P and ESCRT-dependent Ypq1 degradation (Zhu et al., 2017). 
Combining published biochemical and genetic data is potentially a powerful method of 
identifying members of a third PI 3-kinase complex, though there are no obvious 
candidates from published data. Additionally, the possibility that Vps34 and Vps15 can 
function in a binding partner-independent manner cannot be discounted. 
 
Testing hyperactive Vps34 mutants in mammalian cells 
Our studies have revealed that hyperactive Vps34 impacts some downstream pathways 
in yeast cells. Similarly, it will be informative to test the downstream effects of elevating 
PI3P in mammalian systems using hyperactive PIK3C3, the mammalian Vps34 
homolog. Interestingly, despite the importance of PIK3C3 in a number of cellular 
processes, to my knowledge, there are not any well-documented instances of mutations 
in PIK3C3 that cause disease in humans. The lack of disease-associated mutations in 
PIK3C3 may be due to the fact that its proper function is critical for cellular homeostasis. 
Homozygous PIK3C3 null mice are embryonic lethal between E7.5 and E8.5 (Zhou et 
al., 2011). Additionally, cell-type specific Cre-lox-mediated knockout of PIK3C3 leads to 
profound defects in cellular function of many cell types, including heart and skeletal 
muscle (Jaber et al., 2012; Reifler et al., 2014), sensory and pyramidal neurons (Zhou 
et al., 2010; Wang et al., 2011), T cells (Willinger and Flavell, 2012), kidney podocytes 
(Bechtel et al., 2013), and liver cells (Jaber et al., 2012). Inhibition of PIK3C3 has been 
proposed as a potential treatment for some types of cancer (Miaczynska and Zerial, 
2002; Noman et al., 2020), though PIK3C3 inhibitors are only in preclinical evaluation 
(Mulcahy Levy and Thorburn, 2020). 
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Despite the limited disease-relevance of PIK3C3, studying the downstream effects of 
using hyperactive PIK3C3 to elevate PI3P in mammalian systems is critical to 
understanding the role PI3P plays in regulating PI3P-dependent processes. From a 
published sequence alignment of yeast Vps34 with PIK3C3 (Miller et al., 2010), the 
hyperactive mutants R283, A287, and Y501 in yeast Vps34 correspond with K272, 
S276, and Y492 in human PIK3C3. With Y501/Y492 being conserved and R283/K272 
maintaining a basic side chain, it is likely that these mutations in human PIK3C3 will 
elevate PI3P levels in mammalian cells. Intriguingly, the fact that the negatively charged 
hyperactive A287D mutant in yeast Vps34 corresponds to S276 in human PIK3C3 
raises the possibility that S276 has evolved as a phosphosite that regulates PIK3C3 
activity. This possibility can be tested mammalian systems. Because many of the PI3P-
dependent processes we tested in yeast are well-conserved in mammalian systems, 
including retrograde transport, ESCRT, and autophagy, if these mutations in PIK3C3 
are hyperactive, we can test whether elevating PI3P has similar or different effects in 
yeast and mammalian systems. 
 
Yeast Vps34 also has some homology with the helical and kinase domains of the 
mammalian PI(4,5)P2 3-kinases p110α (PIK3CA), p110β (PIK3CB), and p110γ 
(PIK3CG) that catalyze the phosphorylation of PI(4,5)P2 to PI(3,4,5)P3 (Miller et al., 
2010). p110α is of particular interest because multiple somatic mutations that activate 
p110α are associated with colorectal (Samuels et al., 2004) and other forms of cancer  
(reviewed in (Samuels and Waldman, 2010)). Interestingly, using a sequence alignment 
of yeast Vps34 with p110α (Miller et al., 2010), we noted that the hyperactive E505 
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mutant in yeast Vps34 identified in our screen is conserved as E674 in p110α. It is 
possible that mutation of E674 will activate mammalian p110α. Indeed, mutations at 
E674 in p110α have been identified in the COSMIC (catalogue of somatic mutations in 
cancer) database. However, we also generated mutations in yeast Vps34 at residues 
that correspond with mutations in human p110α that were listed multiple times in the 
COSMIC database, yet none of these mutants increased PI3P levels (Figure 3.10). This 





Figure 3.1: Knockout of Vps34 may not lead to a complete loss of PI3P in yeast. 
Comparing elution profiles of PPI lipids separated by anion exchange chromatography 
between wild-type and vps34D yeast cells. In vps34D cells, a small peak elutes at the 
same location where the PI3P peak elutes in wild-type cells. This small peak contains 
approximately 6% of the material contained in wild-type cells. Peaks are truncated at 




Figure 3.2: Only some hyperactive Vps34 mutations rescue growth of the K759D 
mutant. The Vps34-K759D mutant exhibits a growth defect at 33°C when grown on 8 
nM Rapamycin, 0.5M CaCl2 or on 1.5M Ethylene Glycol. This growth defect is rescued 





Figure 3.3: All hyperactive Vps34 mutants tested are able to rescue growth of a 
vps30Δ yeast strain on 15mM ZnSO4 at 33°C. vps30Δvps34Δ cells were transformed 
with a wild-type or mutant Vps34 plasmid and plated on Sc-URA plates (left). These 
cells were replica plated to Sc-URA plates containing 15mM ZnSO4 and grown at 33°C 
(right). While cells containing the wild-type Vps34 plasmid exhibit a growth defect, this 
growth defect is rescued by all hyperactive Vps34 mutants that were tested: Y501C, 





Figure 3.4: New screening conditions for hyperactive mutations in Vps34. A 
screen for hyperactive mutations in Vps34 was designed to identify mutants that rescue 
growth of vps30D cells. The N-terminal half of Vps34 was PCR amplified using 
mutagenic Taq DNA polymerase and a Vps34 plasmid was cut with restriction enzyme, 
HindIII, to remove the region of Vps34 that was mutated. The plasmid backbone and 
mutated PCR fragment were co-transformed into vps30Dvps34D cells. Two days 
following co-transformation, colonies were replica plated to plates containing 15 mM 
ZnSO4 and grown at 33°C. Mutant Vps34 plasmids were isolated from colonies that 
rescued growth on ZnSO4 at 33°C and retransformed into vps30Dvps34D cells to 
confirm rescued growth on ZnSO4 at 33°C. Sanger sequencing was used to identify the 




Figure 3.5: Mutations in Vps34 plasmids that were isolated from colonies that 
rescue growth of vps30Δ cells grown at 33°C on plates containing 15mM ZnSO4. 
Sanger sequencing was used to identify the mutations present in 25 Vps34 plasmids 
isolated from colonies that rescue growth of vps30Δ cells grown at 33°C on plates 
containing 15mM ZnSO4. If multiple mutations were present in a plasmid, the mutation 
though most likely to be causative was listed on the left. Mutations that did not affect the 
Vps34 amino acid sequence are highlighted in green. Mutations highlighted in orange, 
yellow, and blue indicate mutations that were isolated more than once and/or are within 
3 amino acids of another isolated mutation. Instances of the same mutation isolated 
from different PCR reactions indicate independent generation of the mutation, whereas 




Figure 3.6: Crystal structure of the helical and kinase domains of Vps34, 
indicating residues identified in the hyperactive Vps34 mutant screen. Some of the 
residues identified in the screen for hyperactive Vps34 alleles are colored in red (L345, 
L350, E355, R356, S386, S389), while residues that were tested for changes in PPI lipid 
levels are colored in pink (E353, R388, E417). The alpha-C helix (gray) of the kinase 
domain (dark blue), the activation (cyan) and catalytic (orange) loops of Vps34 as well 
as the helical domain (light blue), and the alpha-helix N-terminal to the helical domain of 





Figure 3.7: Vps34 mutations based on mutants obtained from a hyperactive 
mutant screen do not elevate PI3P. vps34D cells were transformed with a wild-type or 
mutant pRS416-Vps34 plasmid. PPI lipid levels were measured by metabolically 
labeling cells with myo-3H-inositol for 16 h, harvesting cells, and separating PPI lipid 
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Figure 3.8: PI 3-kinase complex II is required for proper Mrl1-Envy localization. 
The mannose 6-phosphate receptor Mrl1-Envy localizes to Golgi in wild-type cells. Loss 
of PI 3-kinase activity in vps15D and vps34D cells resulted in a mislocalization of Mrl1-
Envy to the vacuole. While Mrl1-Envy localizes normally in atg14D cells, it mislocalizes 
to the vacuole in vps30D and vps38D cells, indicating that its recycling depends on PI 3-




Figure 3.9: While Vps34 and Vps15 are necessary for internalization of Ypq1-SBP-
EGFP, neither PI 3-kinase complex I or II is required. Ypq1 is a vacuolar cationic 
amino acid transporter. When tagged with SBP-EGFP, Ypq1-SBP-EGFP is 
constitutively sorted into the vacuole lumen in an ESCRT-dependent manner (Zhu et al., 
2017). In the absence of Vps34 or Vps15, Ypq1-SBP-EGFP is not delivered to the 
vacuole lumen, remaining on the vacuole membrane, suggesting that PI3P is required 
for this process. However, simultaneously disrupting PI 3-kinase complexes I and II by 
mutating Vps30 or Vps38 and Atg14 simultaneously did not affect the vacuole lumen 
localization of Ypq1-SBP-EGFP, suggesting a complex I and II-independent role for 





Figure 3.10: Yeast Vps34 mutations at residues that correspond with mutations in 
human p110α that were listed multiple times in the COSMIC database do not 
elevate PI3P. P314, C717, G730, and A843 in yeast Vps34 correspond with P539, 
C901, G914, and A1035 in human p110α. vps34D cells were transformed with a wild-
type or mutant pRS416-Vps34 plasmid. PPI lipid levels were measured by metabolically 
labeling cells with myo-3H-inositol for 16 h, harvesting cells, and separating PPI lipid 
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Yeast strains, plasmids, and media 
Yeast cultures were grown in yeast extract peptone dextrose (YEPD) containing 1% 
yeast extract, 2% peptone and 2% dextrose or synthetic complete (SC) media lacking 
the indicated amino acid(s) at 24°C unless specified. For nitrogen starvation, yeast 
strains were cultured in SD-N medium containing 0.19% yeast nitrogen base, 2% 
glucose, and vitamins and lacking amino acids and ammonium sulfate (Formedium). 
Yeast strains and plasmids are listed in Tables 4.1 and 4.2, respectively. 
 
Phosphoinositide lipid labeling and quantification 
Yeast myo-3H-inositol labeling and total cellular phosphoinositide extraction, 
deacylation, and measurements were performed as described (Bonangelino et al., 
2002; Duex et al., 2006). Briefly, cells were grown in the appropriate SC media to mid-
log phase, washed with SC media lacking inositol, and used to inoculate 5 mL of SC 
media lacking inositol and containing 50 μCi of myo-3H-inositol. Cells were grown for 16 
h shaking at 24°C, harvested by centrifugation, and resuspended in 100 μL inositol-free 
 
3 This chapter is adapted from a published paper: Steinfeld, N., Lahiri, V., Morrison, A., Metur, S.P., 
Klionsky, D.J., and Weisman, L.S. (2021). Elevating PI3P drives select downstream membrane trafficking 
pathways. Mol Biol Cell 32, 143-156. 
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media. For hyperosmotic shock, 100 μL of inositol-free media with 1.8M NaCl was 
added to the sample for 10 min. For basal conditions, 100 μL of inositol-free media was 
added to the 100-μL sample. Cells were then killed via addition of ice-cold 4.5% 
perchloric acid. Cells were lysed using a mini-beadbeater for 2 min, then immediately 
put on ice for 2 min. This was repeated two more times for a total lysis time of 6 min. 
Cell extracts were centrifuged at 16,000 x g for 10 min at room temperature. Pellets 
were washed with 1 mL of 100 mM EDTA pH 8.0 then resuspended in 50 μL distilled 
deionized water (ddH2O). Samples were deacylated with 1 mL methylamine reagent for 
1 h at 55°C, then dried in a speed vac concentrator. Pellets were resuspended in 300 
μL of ddH2O, mixed with 300 μL of a 20:4:1 mixture of butanol/ethyl ether/formic acid 
ethyl ester, vortexed, and centrifuged for 2 min at 16,000 x g. The lower aqueous phase 
was then transferred to a fresh microcentrifuge tube. This sample extraction was 
repeated, and samples were dried in a speed vac concentrator. Dried samples were 
resuspended in 60 μL ddH2O and analyzed by HPLC using a SAX anion exchange 
column. Buffer A (ddH2O) and Buffer B (1 M (NH4)2HPO4, pH 3.8) are used to generate 
the following gradients run at a 1 mL/min flow rate: 1% Buffer B for 5 min, 1–20% Buffer 
B for 44 min, 20–50% Buffer B for 3.75 min, and 50% Buffer B for 8 min. To quantify 
scintillation counts from each sample, the raw counts in each peak were expressed as a 
percentage of total phosphatidylinositol-related species, calculated from summation of 
the counts of the five glycero-inositol peaks present in yeast (PI, PI3P, PI4P, PI(3,5)P2, 
and PI(4,5)P2). Background scintillation counts were calculated from adjacent regions 
and subtracted from all peaks. 
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Screen for hyperactive Vps34 mutants 
Schematic of screen shown in Figure 2.3A. A pRS416-Vps34-K759D plasmid was 
gapped by digesting with XhoI restriction enzyme. The gapped plasmid was purified by 
agarose electrophoresis followed by DNA purification (Qiagen). Primers AM30 (5-
GAATTCACTATTGTGGATGCCGTATCTTCG-3) and AM31 (5-
GGGTAACGCCAGGGTTTTCC-3) were used to PCR amplify the gapped region along 
with approximately 100 bases upstream and downstream of the XhoI restriction sites 
using error-prone Taq DNA polymerase (Invitrogen). Gapped plasmid backbone and 
mutated PCR product were co-transformed into vps34∆ cells. Two days following co-
transformation, colonies were replica plated to plates containing 10 nM rapamycin and 
grown at 33°C. From an estimated 12,000 colonies, mutant Vps34 plasmids were 
isolated from 59 single colonies that rescued growth on rapamycin at 33°C and 
amplified in E. coli. When mutant plasmids were retransformed into vps34∆ cells, 33 of 
the 59 plasmids rescued growth on rapamycin at 33°C. Sanger sequencing of those 33 
plasmids revealed that 11 plasmids contained a mutation at the D759 locus. The 22 
remaining independent mutants indicated 9 unique point mutations. Of those 9 
mutations, changes at 5 of them elevated PI3P levels. 
 
Fluorescence microscopy 
Yeast cells were grown in the appropriate SC media to mid-log phase. Live cell images 
were obtained on a DeltaVision Restoration system (Applied Precision) using an 
inverted epifluorescence microscope (IX-71; Olympus) with a charge-coupled device 
camera (Cool-SNAP HQ; Photometrics) and processed in FIJI. When vacuoles were 
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visualized, cells were labeled with 12 μg FM 4-64 in 250 μl media for 1 h, then washed 
twice and grown in 5 ml fresh SC media for one doubling time (2-3 h) (Vida and Emr, 
1995). 
 
Quantification of fluorescence microscopy images 
Quantification of the number of vacuole lobes, the number of cells with Atg27-2xGFP 
visible on the vacuole, the number of GFP-Atg8 puncta, and the colocalization of GFP-
Atg8 puncta with Atg18-RFP puncta was performed by a scorer who was blinded to the 
genotype of the cells being quantified. 
 
The amount of Envy-Vps34, Fab1-Envy, or Fig4-Envy that colocalized with the vacuole 
was measured using FIJI. Background fluorescence was subtracted using a 5.0 pixel 
rolling ball radius in the green channel and a 10.0 pixel rolling ball radius in the FM 4-64 
channel. FM 4-64 images were thresholded such that pixels with signal present were 
set to 1 and pixels without signal present were set to 0 using the Otsu method. Total 
signal that colocalizes with the vacuole was calculated by multiplying the background 
subtracted green channel image by the FM 4-64 thresholded image and determining the 
integrated intensity of the resulting image. The total colocalized green signal was 
divided by the number of cells in the quantified images to give the green signal intensity 
on the vacuole per cell. 
 
Colocalization of Atg27-2xGFP with FM 4-64, Sec7-mCherry, or Vps8-mCherry was 
measured using FIJI. Background fluorescence was subtracted using a 5.0 pixel rolling 
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ball radius and images were thresholded such that pixels with signal present were set to 
1 and pixels without signal present were set to 0. The Otsu method was used, except 
for Vps8-mCherry where the Renyi Entropy method was used. Total Atg27-2xGFP 
signal was calculated by multiplying the background subtracted Atg27-2xGFP image by 
the Atg27-2xGFP thresholded image and determining the integrated intensity of the 
resulting image. The Atg27-2xGFP signal that colocalized with FM 4-64, Sec7-mCherry, 
or Vps8-mCherry was calculated by multiplying the Atg27-2xGFP thresholded image 
and the FM 4-64/Sec7-mCherry/Vps8-mCherry thresholded image. The resulting image 
was multiplied by the background subtracted Atg27-2xGFP image and integrated 
intensity of the resulting image was determined. Colocalized Atg27-2xGFP signal was 
divided by total Atg27-2xGFP signal to calculate percent overlap. 
 
Western blot analysis 
Yeast cells were grown in the appropriate SC media to mid-log phase. Before 
harvesting, cells were treated in the appropriate experiment-specific conditions. For 
Ypq1-GFP and Mup1-GFP degradation assays, cells were washed twice in lysine-free 
SC media before resuspending in lysine-free SC media or resuspended in SC media 
containing methionine, respectively (Zhu et al., 2017). For Atg8–PE and GFP-Atg8 
assays, cells were shifted to nitrogen-starvation media (-N) for autophagy induction. 
One OD of cells was harvested, and 100 μL urea lysis buffer was added (1% SDS, 8 M 
urea, 10 mM Tris, pH 6.8, 10 mM EDTA, 0.01% bromophenol blue, 0.2% β-
mercaptoethanol, Roche complete protease inhibitor cocktail). One-half volume of 0.5 
mm Zirconia glass beads were added and tubes were vortexed in a micro tube mixer for 
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10 min at 4°C. Supernatants were transferred to fresh tubes and samples were heated 
for 10 min at 75°C and run on an SDS polyacrylamide gel. Proteins were transferred to 
a nitrocellulose membrane at 60V for 16 h. Membranes were blocked in 5% milk before 
incubation with the indicated primary antibody. Membranes were washed 3 times for 5 
min in TBST, incubated in secondary antibodies, washed again, developed with ECL 
prime (GE Healthcare, Pgk1) or Clarity Max (Bio-Rad, other antibodies), imaged on a 
Bio-Rad ChemiDoc imager, and quantified using FIJI. For immunoblot analyses, the 
following antibodies were used: mouse anti-GFP (1:1,000; Roche), mouse anti-Myc 
(1:1,000; clone 9E10 EMD, Millipore), mouse anti-Pgk1 (1:10,000; Invitrogen), mouse 
anti-Vph1 (1:1,000; Abcam), rabbit anti-Atg8 (described previously (Huang et al., 
2000)), mouse anti-Dpm1 (1:5,000; ThermoFisher), mouse anti-HA (1;1,000; Covance 
MMS-101P). 
 
Analysis of Mup1-GFP degradation 
Mup1-GFP levels were normalized to Pgk1. A linear mixed-effects model was used to 
assess the degradation rate of Mup1-GFP. The logarithmic transformation of Mup1-GFP 
levels was modelled as a linear function of time and allowed to vary by genotype. 
Replicate-specific intercepts were included to account for residual correlation between 
protein levels within the same replicate. A 95% confidence interval of the genotype by 
time interaction was used to determine whether there were statistically significant 




Hyperosmotic shock growth assay 
Yeast cells were grown to mid-log phase in SC media and then diluted to equal 
concentrations. An equal volume of SC media or SC media with 1.8 M NaCl was added 
to the culture to begin the time-course. ODs were measured immediately following the 
addition of SC media or SC media with 1.8 M NaCl and then every 4 h for 24 h. The 
time zero OD measurement for each sample was normalized to 1. A natural logarithmic 
transformation was applied to the normalized ODs so that exponential growth is 
represented linearly. 
 
Real-time quantitative PCR (RT-qPCR) 
Yeast were cultured in the appropriate SC media to mid-log phase and then shifted to 
nitrogen-starvation media (-N) for 30 min for autophagy induction. Cells were collected 
and flash frozen in liquid nitrogen. Total RNA was extracted using an RNA extraction kit 
(Clontech, Nucleo Spin RNA, 740955.250). Reverse transcription was carried out using 
the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems/Thermo Fisher 
Scientific, 4368814). For each sample, 1 μg RNA was used for cDNA synthesis. RT-
qPCR was performed using the Radiant SYBR Green Lo-ROX qPCR kit (Alkali 
Scientific) in a CFX Connect (Bio-Rad, 1855201) real-time PCR machine. For all RT-
qPCR experiments, melting curves were run after the PCR cycles to verify primer 
specificity. Relative gene expression was calculated using the 2−ΔΔCT method and 




Nitrogen starvation survival assay 
Yeast cells were grown to mid-log phase in SC media. Equal numbers of cells were 
collected and rinsed twice in nitrogen-starvation media before resuspending in nitrogen-
starvation media. Following 1 day and 14 days of nitrogen starvation, equal volumes of 
culture were serially diluted 1:5 and spotted on SC plates. Plates were imaged following 
3 days of yeast growth. 
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Table 4.1. Yeast strains used in this study 
 
Strain Genotype Source 
LWY13700 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 
lys2-801, suc2-Δ9, vps34Δ::KAN 
(Steinfeld et 
al., 2021) 
LWY19264 MATalpha, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 
lys2-801, suc2-Δ9, vps34Δ::KAN, Atg27-2xGFP::HIS3 
(Steinfeld et 
al., 2021) 
LWY19252 MATalpha, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 




LWY19306 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 




LWY19358 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 




LWY19146 MATalpha, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 
lys2-801, suc2-Δ9, vps34Δ::HYG 
(Steinfeld et 
al., 2021) 
LWY19144 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 
lys2-801, suc2-Δ9, vps34Δ::HYG, ymr1Δ::HIS3 
(Steinfeld et 
al., 2021) 
LWY19450 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 
lys2-801, suc2-Δ9, vps34Δ::HYG, Atg18-RFP::TRP1 
(Steinfeld et 
al., 2021) 
LWY19453 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 




LWY7235 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 
lys2-801, suc2-Δ9 
(Bonangelino 
et al., 1997)  
LWY19518 MATa, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 




LWY19521 MATalpha, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 




LWY19503 MATalpha, leu2,3-112, ura3-52, his3-Δ200, trp1-Δ901, 





Table 4.2. Yeast plasmids used in this study 
 
Plasmid Description Source 
pRS416-Vps34 CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-R283E 
A287D 
CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-Y501C CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-EDC CEN, URA3 (Steinfeld et al., 2021) 
pRS414-Ypq1-GFP CEN, TRP1 Subcloned from (Li et al., 2015) 
pRS414-Mup1-GFP CEN, TRP1 Subcloned from (Lin et al., 2008) 
pRS414-GFP-Atg8 CEN, URA3 (Abeliovich et al., 2003) 
pRS414-pCup1-GFP-Atg8 CEN, TRP1 (Abeliovich et al., 2003) 
pRS413-GFP-Atg8 CEN, HIS3 Subcloned from (Abeliovich et al., 
2003) 
pRS426-GFP-Vps34 2μ, URA3 (Steinfeld et al., 2021) 
pRS425-Vps15-13xMyc 2μ, LEU2 (Steinfeld et al., 2021) 
pRS416-Vps34-D275K CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-R283E CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-A287D CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-N292D CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-H322A CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-E323D CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-F761Y CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-I863D CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34- D275K 
R283E A287D N292D 
CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-D275K 
R283E A287D N292D 
H322A 
CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-K759D CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-E505G CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-S506P CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-D628V CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Vps34-M642V CEN, URA3 (Steinfeld et al., 2021) 
pRS416-5xHA-Vps34 CEN, URA3 (Steinfeld et al., 2021) 
pRS416-5xHA-Vps34-EDC CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Envy-Vps34 CEN, URA3 (Steinfeld et al., 2021) 
pRS416-Envy-Vps34-EDC CEN, URA3 (Steinfeld et al., 2021) 
pRS413-Vps34 CEN, HIS3 (Steinfeld et al., 2021) 
pRS413-Vps34-EDC CEN, HIS3 (Steinfeld et al., 2021) 
pRS416-Fab1-Envy CEN, URA3 (Steinfeld et al., 2021) 
pRS413-Fig4-Envy CEN, HIS3 (Steinfeld et al., 2021) 
pRS416-GFP-Yck3 CEN, URA3 (Steinfeld et al., 2021) 
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